USRE45921E1 - Tissue resection device, system, and method - Google Patents

Tissue resection device, system, and method Download PDF

Info

Publication number
USRE45921E1
USRE45921E1 US13/293,079 US201113293079A USRE45921E US RE45921 E1 USRE45921 E1 US RE45921E1 US 201113293079 A US201113293079 A US 201113293079A US RE45921 E USRE45921 E US RE45921E
Authority
US
United States
Prior art keywords
tissue
sheath
lung
delivery device
body tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related, expires
Application number
US13/293,079
Inventor
Clifton A. Alferness
Hugo X. Gonzalez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gyrus ACMI Inc
Original Assignee
Spiration Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spiration Inc filed Critical Spiration Inc
Priority to US13/293,079 priority Critical patent/USRE45921E1/en
Application granted granted Critical
Publication of USRE45921E1 publication Critical patent/USRE45921E1/en
Assigned to GYRUS ACMI, INC. reassignment GYRUS ACMI, INC. MERGER (SEE DOCUMENT FOR DETAILS). Assignors: SPIRATION, INC.
Adjusted expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0063Implantable repair or support meshes, e.g. hernia meshes

Definitions

  • the present invention is generally directed to an apparatus and method for resectioning body tissue.
  • the present invention is more particularly directed to such an apparatus and method which may be used on various types of body tissue and which greatly simplifies resection procedures.
  • COPD Chronic Obstructive Pulmonary Disease
  • Improvements in pulmonary function after LVRS have been attributed to at least four possible mechanisms. These include enhanced elastic recoil, correction of ventilation/perfusion mismatch, improved efficiency of respiratory musculature, and improved right ventricular filling.
  • Air leaks in lungs can be caused by other causes. With increasing age, a patient may develop a weakened section of lung which may then rupture due to an extreme pressure differential, such as may result from simply a hard sneeze. Patients with AIDS and pulmonary complications can suffer from air leaks. Air leaks in lungs can further be produced by direct trauma such as a puncture from a broken rib or a stab wound.
  • the invention disclosed and claimed in copending U.S. Pat. No. 6,328,689 B1 provides an improved therapy for treating COPD.
  • the improved therapy includes a lung constriction device and method for suppressing such air leaks in lung tissue which does not require any suturing of the effected lung tissue. Still further, by constricting a large enough portion of a lung, lung volume reduction with the concomitant improved pulmonary function may be obtained without the need for any suturing of lung tissue at all.
  • the lung constriction device includes a jacket of flexible material configured to cover at least a portion of a lung.
  • the jacket has a pair of opened ends to permit the lung portion to be drawn into the jacket.
  • the jacket is dimensioned to constrict the lung portion after the lung portion is drawn therein.
  • the lung constriction device is preferably formed of expandable material for receiving the lung portion when forced into an expanded enlarged condition by an expansion force, and then contractible about the lung portion upon release of the expansion force for constricting the lung portion.
  • Devices and methods similar to those disclosed in U.S. Pat. No. 6,328,689 B1 may be employed to advantage in other and different procedures such as in general resection procedures and for body tissue.
  • Resection procedures are commonly performed for such body tissue as, for example, atrial appendage tissue, ovarian tissue, gall bladder tissue, pancreatic tissue, appendix tissue and spleen tissue.
  • Resection procedures may be required to treat cancer, organ damage, or organ disease for example.
  • the present invention provides an improved method for use in body tissue resection.
  • the invention therefore provides a method of resectioning body tissue which may find many applications for encapsulation, isolation, and resection of body tissue. More particularly, among its many applications, the present invention may be employed for removal of diseased tissue, nodules and tumors, for example.
  • the method includes the steps of providing a sheath formed of severable material having opposed opened ends, drawing the body tissue other than lung tissue to be resectioned into the sheath to confine and constrict the soft tissue within the sheath, and severing the sheath and the body tissue within the sheath intermediate the opposed opened ends of the sheath.
  • the invention further provides a device for use in resectioning body tissue.
  • the device comprises a sheath of severable material, the sheath having a pair of opened ends for receiving the body tissue and the sheath being dimensioned for containing and constricting the body tissue.
  • the invention further provides a system for resectioning body tissue.
  • the system includes a sheath of severable material, the sheath having a pair of opened ends for receiving the tissue and the sheath being dimensioned for containing and constricting the tissue, means for drawing the tissue into the sheath to constrict and isolate the tissue, and means for severing the sheath to resection the tissue.
  • FIG. 1 is a simplified sectional view of a thorax illustrating a healthy respiratory system
  • FIG. 2 is a sectional view similar to FIG. 1 but illustrating a respiratory system suffering from an air leak in a lung lobe;
  • FIG. 3 is a sectional view illustrating the lung lobe having the air leak in a deflated condition due to the air leak;
  • FIG. 4 is a sectional view of the respiratory system of FIG. 2 with a resection device embodying the present invention being disposed over a lung portion to be constricted for suppressing the air leak;
  • FIG. 5 is a sectional view illustrating the resection device constricting the effected lung portion and suppressing the air leak;
  • FIG. 6 illustrates a resection device embodying the present invention and a mandrel which may be used in a mechanical method embodying the present invention for deploying the resection device;
  • FIG. 7 illustrates an initial step in practicing the mechanical method of deployment embodying the present invention
  • FIG. 8 illustrates a further step in the mechanical deployment of the resection device
  • FIG. 9 illustrates the step of pulling the lung portion to be constricted into the resection device in accordance with the mechanical method embodiment
  • FIG. 10 illustrates the manner in which an expansion force may be released from the resection device as a final step in deploying the resection device in accordance with the mechanical method embodiment
  • FIG. 11 illustrates the resection device fully deployed as a result of the mechanical method embodiment illustrated in FIGS. 6-10 ;
  • FIG. 12 illustrates an initial step of a further method of deploying the resection device in accordance with further aspects of the present invention
  • FIG. 13 illustrates an intermediate step in the further method embodiment of deploying the resection device
  • FIG. 14 illustrates a final step in the further method embodiment of deploying the resection device
  • FIG. 15 illustrates an initial step of a still further method of deploying the resection device in accordance with further aspects of the present invention
  • FIG. 16 illustrates an intermediate step in the still further method embodiment of deploying the resection device
  • FIG. 17 illustrates a final step in the still further method embodiment of deploying the resection device
  • FIG. 18 is a sectional view illustrating the resection device constricting a lung portion to be resectioned for lung volume reduction
  • FIG. 19 illustrates the lung portion after being resectioned in accordance with a further embodiment of the present invention.
  • FIG. 20 is a partial perspective view of a heart illustrating a resection device of the present invention constricting a portion of the left atrial tissue after being deployed thereon;
  • FIG. 21 is a partial perspective view of the heart illustrating the restriction device after being severed for resectioning the left atrial tissue
  • FIG. 22 is a partial cross sectional view of the remaining resection device and left atrial tissue after the resection of the left atrium;
  • FIG. 23 is a perspective view of an ovary illustrating a resection device of the present invention constricting a portion of the ovary tissue after being deployed thereon;
  • FIG. 24 is a partial perspective view of the ovary illustrating the restriction device after being severed for resectioning the ovary tissue
  • FIG. 25 is a partial cross sectional view of the remaining resection device and ovary tissue after the resection of the ovary;
  • FIG. 26 is a perspective view of a gall bladder illustrating a resection device of the present invention constricting a portion of the gall bladder tissue after being deployed thereon;
  • FIG. 27 is a partial perspective view of the gall bladder illustrating the restriction device after being severed for resectioning the gall bladder tissue
  • FIG. 28 is a partial cross sectional view of the remaining resection device and gall bladder tissue after the resection of the gall bladder;
  • FIG. 29 is a perspective view of a pancreas illustrating a resection device of the present invention constricting a portion of the pancreas tissue after being deployed thereon;
  • FIG. 30 is a partial perspective view of the pancreas illustrating the restriction device after being severed for resectioning the pancreas tissue;
  • FIG. 31 is a partial cross sectional view of the remaining resection device and pancreas tissue after the resection of the pancreas;
  • FIG. 32 is a partial perspective view of an intestine and appendix illustrating a resection device of the present invention constricting a portion of the appendix tissue after being deployed thereon;
  • FIG. 33 is a partial perspective view of the intestine and appendix illustrating the restriction device after being severed for resectioning the appendix tissue;
  • FIG. 34 is a partial cross sectional view of the remaining resection device and intestine and appendix tissue after the resection of the appendix tissue;
  • FIG. 35 is a perspective view of a spleen illustrating a resection device of the present invention constricting a portion of the spleen tissue after being deployed thereon;
  • FIG. 36 is a partial perspective view of the spleen illustrating the restriction device after being severed for resectioning the spleen tissue.
  • FIG. 37 is a partial cross sectional view of the remaining resection device and spleen tissue after the resection of the spleen.
  • FIG. 1 it is a sectional view of a healthy respiratory system.
  • the respiratory system 20 resides within the thorax 22 which occupies a space defined by the chest wall 24 and the diaphragm 26 .
  • the respiratory system 20 includes the trachea 28 , the left mainstem bronchus 30 , the right mainstem bronchus 32 , and the bronchial branches 34 , 36 , 38 , 40 , and 42 .
  • the respiratory system 20 further includes left lung lobes 52 and 54 and right lung lobes 56 , 58 , and 60 .
  • Each bronchial branch communicates with a respective different portion of a lung lobe, either the entire lung lobe or a portion thereof.
  • a healthy respiratory system has an arched or inwardly arcuate diaphragm 26 .
  • the diaphragm 26 straightens as illustrated in FIG. 1 to increase the volume of the thorax 22 .
  • This causes a negative pressure within the thorax.
  • the negative pressure within the thorax in turn causes the lung lobes to fill with air to an inflated condition as illustrated in FIG. 1 .
  • the diaphragm returns to its original arched condition to decrease the volume of the thorax.
  • the decreased volume of the thorax causes a positive pressure within the thorax which in turn causes exhalation of the lung lobes.
  • FIG. 2 illustrates the respiratory system 20 just after suffering an air leak or rupture.
  • the rupture 62 has occurred in lung lobe 58 .
  • air is escaping from the lung lobe 58 as indicated by the arrow 64 .
  • This individual is incapable of breathing normally.
  • the negative pressure created by the moving diaphragm 26 causes some of the air taken into lobe 58 to be lost through the rupture 62 .
  • the positive pressure produced thereby forces still more air from lobe 58 through the rupture.
  • the lobe 58 collapses as illustrated in FIG. 3 and becomes nonfunctional to support respiration.
  • FIG. 4 shows a constriction and resection device 70 embodying the present invention in the process of being deployed on the effected lung lobe 58 .
  • the device 70 is configured as a jacket of sheath formed of a sheet or flexible fabric of biocompatible material.
  • the material may be both flexible and expandable material formed from silicone rubber, polyurethane, expanded polytetraflouroethylene, polyester and polyurethane, or nylon and polyurethane, for example. It may alternatively be flexible but nonexpendable formed from nylon, polytetraflouroethylene, or polyester, for example.
  • the sheath is expandable, it may more specifically be formed from a sheet or fabric of 70% nylon and 30% polyurethane.
  • the sheath is preferably opened at both ends 72 and 74 and, as illustrated, may be generally cylindrical in configuration.
  • the sheath is applied to the portion of the lung lobe having the leak or puncture while the jacket is in an expanded condition. This may be accomplished, as will be seen hereinafter, by expanding the jacket and then pulling the lung portion into the jacket.
  • the expansion of the device is released as seen, for example, in FIG. 5 . With the expansion released, the sheath is permitted to contract or collapse about the lung portion to constrict the lung portion and effectively suppress the leak or puncture.
  • the lung tissue may be collapsed as it is pulled into the jacket. Once disposed in the sheath, the lung tissue will remain constricted by the sheath.
  • the use of the device 70 need not be restricted to the suppression of air leakages in lungs. It may, for example, find use to advantage in constricting a lung portion suffering from COPD to simulate or achieve lung volume reduction. All of the beneficial effects of lung volume reduction surgery may be realized and, most importantly, without requiring suturing of lung tissue.
  • FIGS. 6-11 illustrate a mechanical process for deploying the device 70 .
  • the device 70 is first aligned with an expansion mandrel or form 80 .
  • the device 70 is then moved towards the form 80 as indicated by the arrow 76 .
  • the form 80 is hollow, has opened ends 82 and 84 and has a configuration similar to that of the device 70 .
  • the form has a longitudinal slit 86 rendering the form expandable in a transverse direction.
  • the form further includes tabs 88 and 90 which, when pressed towards each other, cause the form to expand in the transverse direction.
  • the device 70 is applied to the form 80 until the end 74 of the device 70 is at the end 84 of the form 80 as illustrated in FIG. 7 .
  • An atraumatic instrument such as a forceps 92 , is then aligned with the form 80 and moved relative thereto through the form in the direction of arrow 96 and into engagement with the lung tissue 58 as illustrated in FIG. 8 .
  • the forceps 92 are then used to grab the lung tissue 58 .
  • the tabs 88 and 90 of the form 80 are pressed toward each other to cause the form 80 to expand in a transverse direction. This may be noticed by the longitudinal slit 86 becoming noticeably wider.
  • the expansion of the form 80 in the transverse direction imparts an expansion force on the device 70 , causing it to similarly expand to an expanded condition.
  • the forceps are then retracted as illustrated in FIG. 9 in the direction of arrow 98 , to pull the lung tissue into the form 80 and device 70 .
  • the lung tissue is pulled until it extends entirely through the device 70 .
  • the process continues as illustrated in FIG. 10 .
  • the tabs 88 and 90 are released.
  • the device 70 remains in an expanded condition.
  • a suitable instrument 94 is used to hold the device 70 in place while the form 80 is moved in the direction of the arrow 100 to withdraw the form 80 from the device 70 .
  • the process is completed when the form 80 is totally withdrawn from the device 70 .
  • the expansion force applied to the device 70 by the form 80 is released, permitting the device 70 to collapse or contract about the lung tissue 58 drawn into the device 70 .
  • the device 70 now constricts the lung tissue to effect air leak suppression or lung volume reduction, for example.
  • the form 80 need not be expandable if the device 70 is not expandable.
  • the process of pulling the lung tissue into the mandrel 80 and device 70 will cause the lung tissue to collapse.
  • the device 70 being dimensioned for constricting the lung tissue, once the mandrel is removed, the lung tissue will remain in and be constricted by the device 70 as illustrated in FIG. 11 .
  • the lung tissue within the device 70 is also now ready to be resectioned. This may be accomplished by severing the device 70 intermediate it's ends using an appropriated bladed instrument.
  • FIGS. 12-14 illustrate another embodiment of deploying the device 70 in accordance with further aspects of the present invention.
  • vacuum pressure is utilized instead for pulling the lung tissue into the device 70 . This permits the procedure to be more automated and potentially less traumatic to the lung tissue being constricted and resectioned.
  • the mandrel or form 110 takes the form of a cylinder having an opened end 112 and a closed end 114 .
  • the closed end 114 is coupled to a vacuum source 116 through a conduit 118 and a valve 120 .
  • the valve 120 has an aperture 122 which, when closed by, for example, a finger 124 , causes the vacuum to be pulled through the conduit 118 and form 110 .
  • the valve is in an opened condition.
  • the form 110 has a diameter dimension 126 which is substantially greater than the diameter dimension of the device 70 when the device is expandable and in a nonexpanded condition. As seen in FIG. 12 , the device 70 has been applied over the form 110 so that the form imparts an expansion force to the device 70 . The opened end 112 of the form 110 is in contact with the lung tissue 58 to be constricted and resectioned.
  • the finger 124 has now closed the valve 120 .
  • the vacuum is now being pulled through the conduit 118 and form 110 . This causes the lung tissue 58 to be pulled into the form 110 and the device 70 while the device 70 is in an expanded condition.
  • the device may be held in position and the form 110 withdrawn from the device 70 and the lung tissue 58 .
  • the vacuum suction may be released by opening the valve 120 .
  • the expansion force of the form 110 on the device 70 is released to permit the device 70 to collapse or contract about the lung tissue 58 .
  • the device 70 is now deployed for constricting the lung tissue and providing leak suppression or lung volume reduction, for example.
  • the device 70 need not be expandable.
  • the form 110 may have the same or approximately the same dimensions as the device 70 .
  • the vacuum suction pulls the lung tissue 58 into the mandrel or form 110 , it will collapse.
  • the lung tissue 58 will remain in the device 70 in a collapsed condition to be constricted by the device 70 .
  • the lung tissue within the device 70 is also ready to be resectioned. Again, this may be accomplished by severing the device 70 intermediate its ends by use of an appropriate bladed instrument.
  • FIGS. 15-17 illustrate a further embodiment of deploying the device 70 on lung tissue 58 to be constricted and resectioned.
  • a vacuum suction is utilized for pulling the lung tissue into the device 70 .
  • the vacuum source 116 , the conduit 118 , and the valve 120 are again used to establish the vacuum suction in the form 110 .
  • the device 70 is positioned inside of the form 110 with the end 74 of the device 70 being stretched and held by the lip 130 of the form 110 .
  • the valve 120 is closed, the vacuum is pulled through the mandrel 110 and the device 70 due to the opened end 72 of the device 70 .
  • the lung tissue 58 is brought into engagement with the end 74 of the device 70 and the vacuum is pulled with the closure of valve 120 , the lung tissue is pulled directly into the device 70 as illustrated in FIG. 16 .
  • the vacuum is pulled until the lung tissue 58 to be constricted preferably extends entirely through the device 70 past the end 72 .
  • the lung tissue itself exerts an expansion force on the device 70 as the lung tissue is pulled into the device 70 .
  • the end 74 of the device 70 may be released from the lip 130 of the form 110 to permit the form 110 to be withdrawn from the device 70 .
  • the vacuum suction may be released by opening the valve 120 .
  • the release of the vacuum also releases the expansion force on the device 70 .
  • the device is permitted to collapse or contract about the lung tissue 58 .
  • the device 70 is now deployed for constricting the lung tissue and providing leak suppression or lung volume reduction, for example.
  • the lung tissue 58 within the device 70 is also in condition for resection. Again, the tissue 58 may be resectioned by severing the device 70 intermediate its ends with a suitable bladed instrument.
  • the form or mandrel 110 may be of the same dimension or slightly larger dimension than the device 70 to permit an effective seal between the lip 130 of mandrel or form 110 and the end 74 of the device 70 .
  • the vacuum suction will still be pulled through the form 110 and the device 70 .
  • the lung tissue collapses.
  • the collapsed lung tissue will remain constricted in the device 70 to provide, for example, lung leakage suppression or lung volume reduction.
  • FIGS. 18 and 19 they more clearly illustrate the manner in which the device 70 may be employed for resectioning the lung tissue to effect lung volume reduction to a greater extent.
  • the lung portion 59 of lobe 58 has been pulled through the device 70 and is being constricted by the device 70 .
  • the device 70 and the manner of pulling the lung portion 59 therethrough may conform to any of the embodiments previously described herein.
  • the device 70 is formed of severable material, such as, any of the materials previously described. This enables the device 70 to be severed or cut intermediate its ends with a suitable bladed instrument 61 as illustrated in FIG. 19 to section the lung portion 59 . The portion of the device 70 remaining on the lobe 58 continues to constrict the lung tissue therein to form an effective seal from leakage. Hence, in accordance with this embodiment of the present invention, lung volume reduction is rendered an available treatment while negating the need of conventional lung sectioning and suturing thus avoiding the potentially severe complications which accompany those procedures.
  • FIGS. 20-22 they illustrate the manner in which the device 70 may be utilized for resectioning heart tissue, such as left atrial appendage tissue.
  • Shown in FIG. 20 is a heart 100 having the device 70 deployed on the left atrial appendage 72 .
  • the device 70 may be deployed in accordance with any of the previously described methods for deployment.
  • the device 70 is deployed by imparting vacuum suction to the left atrial tissue 74 to be resectioned by a vacuum cylinder 76 .
  • the tissue 74 constricted within the device 70 and to be resectioned is resectioned as illustrated in FIG. 21 .
  • the device 70 has been severed intermediate its ends. This results in the resectioning of the tissue 74 .
  • the portion of the device 70 remaining on the left atrial appendage, as seen in FIG. 22 continues to constrict the remaining left atrial appendage tissue 72 and maintains the integrity of the left atrial appendage 72 to prevent leakage and bleeding.
  • resectioning of the heart may be accomplished without suturing by use of the constriction and resection device 70 .
  • This will greatly assist in accelerating the healing process and reducing the potential for infection.
  • FIGS. 23-25 they illustrate the manner in which the device 70 may be utilized for resectioning ovarian tissue.
  • Shown in FIG. 23 is an ovary 110 having the device 70 deployed thereon.
  • the device 70 may be deployed in accordance with any of the previously described methods for deployment.
  • the device 70 is deployed by imparting vacuum suction to the ovarian tissue 84 to be resectioned by the vacuum cylinder 76 .
  • the tissue 84 constricted within the device 70 and to be resectioned is resectioned as illustrated in FIG. 24 .
  • the device 70 has been severed intermediate its ends. This results in the resectioning of the tissue 84 .
  • the portion of the device 70 remaining on the ovary 110 continues to constrict the remaining ovarian tissue 110 and maintains the integrity of the ovary 110 to prevent leakage and bleeding.
  • FIGS. 26-29 they illustrate the manner in which the device 70 may be utilized for resectioning gall bladder tissue. Shown in FIG. 26 is a gall bladder 120 having the device 70 deployed thereon. Again, the device 70 may be deployed in accordance with any of the previously described methods for deployment but preferably is deployed by imparting vacuum suction to the gall bladder tissue 94 to be resectioned by the vacuum cylinder 76 .
  • the gall bladder tissue 94 constricted within the device 70 and to be resectioned is resectioned as illustrated in FIG. 27 .
  • the device 70 has been severed intermediate its ends. This results in the resectioning of the tissue 94 .
  • the portion of the device 70 remaining on the gall bladder 120 continues to constrict the gall bladder tissue 120 to maintain its integrity and to prevent leakage and bleeding.
  • FIGS. 29-31 they illustrate the manner in which the device 70 may be utilized for resectioning pancreatic tissue. Shown in FIG. 29 is a pancreas 130 having the device 70 deployed thereon. The device 70 is preferably deployed by imparting vacuum suction to the pancreatic tissue 104 to be resectioned by the vacuum cylinder 76 . Of course, any of the other methods of deployment may be used as well.
  • the tissue 104 constricted within the device 70 and to be resectioned is resectioned as illustrated in FIG. 30 .
  • the device 70 has been severed intermediate its ends. This results in the resectioning of the tissue 104 .
  • the portion of the device 70 remaining on the pancreas 130 continues to constrict the remaining pancreatic tissue 130 and maintains the integrity of the pancreas to prevent leakage and bleeding.
  • FIGS. 32-34 illustrate the manner in which the device 70 may be utilized for resectioning an appendix 140 from its adjoining intestine 138 .
  • Shown in FIG. 32 is device 70 deployed over the appendix 140 .
  • the device 70 may be deployed in accordance with any of the previously described methods for deployment.
  • the device 70 is deployed by imparting vacuum suction to the appendix tissue 140 to be resectioned by the vacuum cylinder 76 .
  • the appendix tissue 140 constricted within the device 70 and to be resectioned is resectioned as illustrated in FIG. 33 .
  • the device 70 has been severed intermediate its ends. This results in the resectioning of the appendix 140 .
  • the portion of the device 70 remaining on what remains of the appendix 140 maintains the integrity of the intestine 138 to prevent leakage and bleeding.
  • FIGS. 35-37 they illustrate a last example as to how the device 70 may be utilized for resectioning body tissue.
  • spleen tissue is to be resectioned.
  • Shown in FIG. 35 is a spleen 150 having the device 70 deployed thereon.
  • the device 70 may be deployed in accordance with any of the previously mentioned methods for deployment.
  • the device 70 is deployed by imparting vacuum suction to the spleen tissue 154 to be resectioned by a vacuum cylinder 76 .
  • the tissue 154 constricted within the device 70 and to be resectioned is resectioned as illustrated in FIG. 36 .
  • the device 70 has been severed intermediate its ends. This results in the resectioning of the tissue 154 .
  • the portion of the device 70 remaining on the spleen 150 continues to maintain the integrity of the spleen 150 to prevent leakage and bleeding.
  • the resectioning may be accomplished without suturing by use of the constricting and resection device 70 .
  • the present invention provides an improved device and method which may be used to advantage for resectioning body tissue.

Abstract

A resection device and method permits safe and efficient encapsulation, isolation and resection of body tissue. The device includes a sheath of flexible and severable material configured to receive the body tissue to be resectioned as it is drawn therein. The sheath may be expandable and held in an expanded condition as the body tissue to be resectioned is drawn into the sheath. Thereafter, the sheath is permitted to collapse about the body tissue to contain and constrict the body tissue. Once the body tissue to be resectioned is disposed in the sheath, the sheath is severed to resection the body tissue.

Description

RELATED APPLICATIONS
This is a continuation of U.S. application Ser. No. 10/287,188, filed on Nov. 4, 2002, now U.S. Pat. No. 6,790,172 which is a continuation of U.S. application Ser. No. 09/780,232, filed on Feb. 9, 2001, now U.S. Pat. No. 6,485,407, which is a continuation-in-part of U.S. application Ser. No. 09/534,244 filed Mar. 23, 2000, now U.S. Pat. No. 6,328,689, the entirety of which is incorporated herein by reference.
BACKGROUND OF THE INVENTION
The present invention is generally directed to an apparatus and method for resectioning body tissue. The present invention is more particularly directed to such an apparatus and method which may be used on various types of body tissue and which greatly simplifies resection procedures.
Chronic Obstructive Pulmonary Disease (COPD) has become a major cause of morbidity and mortality in the United States over the last three decades. COPD is characterized by the presence of airflow obstruction due to chronic bronchitis or emphysema. The airflow obstruction in COPD is due largely to structural abnormalities in the smaller airways. Important causes are inflammation, fibrosis, goblet cell metaplasia, and smooth muscle hypertrophy in terminal bronchioles.
About 40 years ago, it was first postulated that the tethering force that tends to keep the intrathoracic airways open was lost in emphysema and that by surgically removing the most affected parts of the lungs, through lung volume reduction surgery (LVRS), the force could be partially restored. Although the surgery was deemed promising, the procedure was abandoned.
Lung volume reduction surgery was later revived. In the early 1990's, hundreds of patients underwent the procedure. However, the procedure has fallen out of favor due to the fact that Medicare stopped remitting for LVRS. Unfortunately, data is relatively scarce and many factors conspire to make what data exists difficult to interpret. The procedure is currently under review in a controlled clinical trial. However, what data does exist tends to indicate that patients benefited from the procedure in terms of an increase in forced expiratory volume, a decrease in total lung capacity, and a significant improvement in lung function, dyspnea, and quality of life.
Improvements in pulmonary function after LVRS have been attributed to at least four possible mechanisms. These include enhanced elastic recoil, correction of ventilation/perfusion mismatch, improved efficiency of respiratory musculature, and improved right ventricular filling.
The improvements in pulmonary function resulting from LVRS cannot be ignored. However, the surgery is very invasive and fraught with complications. Among the complications is the potential for lung air leaks. Lung tissue is very thin, and fragile hence difficult to suture together. After a lung portion is sectioned and removed, the remaining lung is most often restructured with suture staples. In about thirty percent (30w) of the cases, the difficulty with suturing lung tissue results in air leaks. Treatment for such air leaks depends upon their severity and often, in the most serious cases, requires further open chest surgery.
Air leaks in lungs can be caused by other causes. With increasing age, a patient may develop a weakened section of lung which may then rupture due to an extreme pressure differential, such as may result from simply a hard sneeze. Patients with AIDS and pulmonary complications can suffer from air leaks. Air leaks in lungs can further be produced by direct trauma such as a puncture from a broken rib or a stab wound.
The invention disclosed and claimed in copending U.S. Pat. No. 6,328,689 B1 provides an improved therapy for treating COPD. The improved therapy includes a lung constriction device and method for suppressing such air leaks in lung tissue which does not require any suturing of the effected lung tissue. Still further, by constricting a large enough portion of a lung, lung volume reduction with the concomitant improved pulmonary function may be obtained without the need for any suturing of lung tissue at all.
More specifically, the lung constriction device includes a jacket of flexible material configured to cover at least a portion of a lung. The jacket has a pair of opened ends to permit the lung portion to be drawn into the jacket. The jacket is dimensioned to constrict the lung portion after the lung portion is drawn therein. The lung constriction device is preferably formed of expandable material for receiving the lung portion when forced into an expanded enlarged condition by an expansion force, and then contractible about the lung portion upon release of the expansion force for constricting the lung portion.
An important aspect of the device and method disclosed in U.S. Pat. No. 6,328,689 B1 is the ability to sever the constricting device intermediate its ends. This allows a significant portion of the constricted lung tissue to be removed altogether while permitting a portion of the constricting device to remain in the body for continued suppression of air leaks and maintenance of the remaining lung tissue integrity.
Devices and methods similar to those disclosed in U.S. Pat. No. 6,328,689 B1 may be employed to advantage in other and different procedures such as in general resection procedures and for body tissue. Resection procedures are commonly performed for such body tissue as, for example, atrial appendage tissue, ovarian tissue, gall bladder tissue, pancreatic tissue, appendix tissue and spleen tissue. Resection procedures may be required to treat cancer, organ damage, or organ disease for example.
Common to all resection procedures is the need to isolate the body tissue to be removed, resection the body tissue to be removed, and then suture the incision. All the while, great care must be taken to avoid infection from external sources and from the diseased tissue being removed. Frequent aspiration of blood and other body fluids, some of which may be contaminated, is often essential. The present invention provides an improved method for use in body tissue resection.
SUMMARY OF THE INVENTION
The invention therefore provides a method of resectioning body tissue which may find many applications for encapsulation, isolation, and resection of body tissue. More particularly, among its many applications, the present invention may be employed for removal of diseased tissue, nodules and tumors, for example. The method includes the steps of providing a sheath formed of severable material having opposed opened ends, drawing the body tissue other than lung tissue to be resectioned into the sheath to confine and constrict the soft tissue within the sheath, and severing the sheath and the body tissue within the sheath intermediate the opposed opened ends of the sheath.
The invention further provides a device for use in resectioning body tissue. The device comprises a sheath of severable material, the sheath having a pair of opened ends for receiving the body tissue and the sheath being dimensioned for containing and constricting the body tissue.
The invention further provides a system for resectioning body tissue. The system includes a sheath of severable material, the sheath having a pair of opened ends for receiving the tissue and the sheath being dimensioned for containing and constricting the tissue, means for drawing the tissue into the sheath to constrict and isolate the tissue, and means for severing the sheath to resection the tissue.
BRIEF DESCRIPTION OF THE DRAWINGS
The features of the present invention which are believed to be novel are set forth with particularity in the appended claims. The invention, together with further objects and advantages thereof, may best be understood by making reference to the following description taken in conjunction with the accompanying drawings, in the several figures of which like reference numerals identify identical elements, and wherein:
FIG. 1 is a simplified sectional view of a thorax illustrating a healthy respiratory system;
FIG. 2 is a sectional view similar to FIG. 1 but illustrating a respiratory system suffering from an air leak in a lung lobe;
FIG. 3 is a sectional view illustrating the lung lobe having the air leak in a deflated condition due to the air leak;
FIG. 4 is a sectional view of the respiratory system of FIG. 2 with a resection device embodying the present invention being disposed over a lung portion to be constricted for suppressing the air leak;
FIG. 5 is a sectional view illustrating the resection device constricting the effected lung portion and suppressing the air leak;
FIG. 6 illustrates a resection device embodying the present invention and a mandrel which may be used in a mechanical method embodying the present invention for deploying the resection device;
FIG. 7 illustrates an initial step in practicing the mechanical method of deployment embodying the present invention;
FIG. 8 illustrates a further step in the mechanical deployment of the resection device;
FIG. 9 illustrates the step of pulling the lung portion to be constricted into the resection device in accordance with the mechanical method embodiment;
FIG. 10 illustrates the manner in which an expansion force may be released from the resection device as a final step in deploying the resection device in accordance with the mechanical method embodiment;
FIG. 11 illustrates the resection device fully deployed as a result of the mechanical method embodiment illustrated in FIGS. 6-10;
FIG. 12 illustrates an initial step of a further method of deploying the resection device in accordance with further aspects of the present invention;
FIG. 13 illustrates an intermediate step in the further method embodiment of deploying the resection device;
FIG. 14 illustrates a final step in the further method embodiment of deploying the resection device;
FIG. 15 illustrates an initial step of a still further method of deploying the resection device in accordance with further aspects of the present invention;
FIG. 16 illustrates an intermediate step in the still further method embodiment of deploying the resection device;
FIG. 17 illustrates a final step in the still further method embodiment of deploying the resection device;
FIG. 18 is a sectional view illustrating the resection device constricting a lung portion to be resectioned for lung volume reduction;
FIG. 19 illustrates the lung portion after being resectioned in accordance with a further embodiment of the present invention;
FIG. 20 is a partial perspective view of a heart illustrating a resection device of the present invention constricting a portion of the left atrial tissue after being deployed thereon;
FIG. 21 is a partial perspective view of the heart illustrating the restriction device after being severed for resectioning the left atrial tissue; FIG. 22 is a partial cross sectional view of the remaining resection device and left atrial tissue after the resection of the left atrium;
FIG. 23 is a perspective view of an ovary illustrating a resection device of the present invention constricting a portion of the ovary tissue after being deployed thereon;
FIG. 24 is a partial perspective view of the ovary illustrating the restriction device after being severed for resectioning the ovary tissue;
FIG. 25 is a partial cross sectional view of the remaining resection device and ovary tissue after the resection of the ovary;
FIG. 26 is a perspective view of a gall bladder illustrating a resection device of the present invention constricting a portion of the gall bladder tissue after being deployed thereon;
FIG. 27 is a partial perspective view of the gall bladder illustrating the restriction device after being severed for resectioning the gall bladder tissue;
FIG. 28 is a partial cross sectional view of the remaining resection device and gall bladder tissue after the resection of the gall bladder;
FIG. 29 is a perspective view of a pancreas illustrating a resection device of the present invention constricting a portion of the pancreas tissue after being deployed thereon;
FIG. 30 is a partial perspective view of the pancreas illustrating the restriction device after being severed for resectioning the pancreas tissue;
FIG. 31 is a partial cross sectional view of the remaining resection device and pancreas tissue after the resection of the pancreas;
FIG. 32 is a partial perspective view of an intestine and appendix illustrating a resection device of the present invention constricting a portion of the appendix tissue after being deployed thereon;
FIG. 33 is a partial perspective view of the intestine and appendix illustrating the restriction device after being severed for resectioning the appendix tissue;
FIG. 34 is a partial cross sectional view of the remaining resection device and intestine and appendix tissue after the resection of the appendix tissue;
FIG. 35 is a perspective view of a spleen illustrating a resection device of the present invention constricting a portion of the spleen tissue after being deployed thereon;
FIG. 36 is a partial perspective view of the spleen illustrating the restriction device after being severed for resectioning the spleen tissue; and
FIG. 37 is a partial cross sectional view of the remaining resection device and spleen tissue after the resection of the spleen.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
Referring now to FIG. 1, it is a sectional view of a healthy respiratory system. The respiratory system 20 resides within the thorax 22 which occupies a space defined by the chest wall 24 and the diaphragm 26.
The respiratory system 20 includes the trachea 28, the left mainstem bronchus 30, the right mainstem bronchus 32, and the bronchial branches 34, 36, 38, 40, and 42. The respiratory system 20 further includes left lung lobes 52 and 54 and right lung lobes 56, 58, and 60. Each bronchial branch communicates with a respective different portion of a lung lobe, either the entire lung lobe or a portion thereof.
A healthy respiratory system has an arched or inwardly arcuate diaphragm 26. As the individual inhales, the diaphragm 26 straightens as illustrated in FIG. 1 to increase the volume of the thorax 22. This causes a negative pressure within the thorax. The negative pressure within the thorax in turn causes the lung lobes to fill with air to an inflated condition as illustrated in FIG. 1. When the individual exhales, the diaphragm returns to its original arched condition to decrease the volume of the thorax. The decreased volume of the thorax causes a positive pressure within the thorax which in turn causes exhalation of the lung lobes.
FIG. 2 illustrates the respiratory system 20 just after suffering an air leak or rupture. Here it may be seen that the rupture 62 has occurred in lung lobe 58. As a result, air is escaping from the lung lobe 58 as indicated by the arrow 64. Hence, this individual is incapable of breathing normally. The negative pressure created by the moving diaphragm 26 causes some of the air taken into lobe 58 to be lost through the rupture 62. When the diaphragm 26 returns to its arched configuration, the positive pressure produced thereby forces still more air from lobe 58 through the rupture. Eventually, within a short time, the lobe 58 collapses as illustrated in FIG. 3 and becomes nonfunctional to support respiration.
FIG. 4 shows a constriction and resection device 70 embodying the present invention in the process of being deployed on the effected lung lobe 58. The device 70 is configured as a jacket of sheath formed of a sheet or flexible fabric of biocompatible material. The material may be both flexible and expandable material formed from silicone rubber, polyurethane, expanded polytetraflouroethylene, polyester and polyurethane, or nylon and polyurethane, for example. It may alternatively be flexible but nonexpendable formed from nylon, polytetraflouroethylene, or polyester, for example. If the sheath is expandable, it may more specifically be formed from a sheet or fabric of 70% nylon and 30% polyurethane. The sheath is preferably opened at both ends 72 and 74 and, as illustrated, may be generally cylindrical in configuration.
In accordance with one embodiment of the present invention, the sheath is applied to the portion of the lung lobe having the leak or puncture while the jacket is in an expanded condition. This may be accomplished, as will be seen hereinafter, by expanding the jacket and then pulling the lung portion into the jacket. When the effected lung portion is thus disposed with respect to the sheath as illustrated in FIG. 4, the expansion of the device is released as seen, for example, in FIG. 5. With the expansion released, the sheath is permitted to contract or collapse about the lung portion to constrict the lung portion and effectively suppress the leak or puncture.
In accordance with a further embodiment, if the flexible sheath is nonexpandable, the lung tissue may be collapsed as it is pulled into the jacket. Once disposed in the sheath, the lung tissue will remain constricted by the sheath.
When the lung portion is thus constricted, the air leakage will be suppressed. The lung lobe 58 thereafter, during successive breaths, will reinflate and become functional once again to support respiration.
The use of the device 70 need not be restricted to the suppression of air leakages in lungs. It may, for example, find use to advantage in constricting a lung portion suffering from COPD to simulate or achieve lung volume reduction. All of the beneficial effects of lung volume reduction surgery may be realized and, most importantly, without requiring suturing of lung tissue.
FIGS. 6-11 illustrate a mechanical process for deploying the device 70. In an initial step, as illustrated in FIG. 6, the device 70 is first aligned with an expansion mandrel or form 80. The device 70 is then moved towards the form 80 as indicated by the arrow 76.
In accordance with this embodiment, the form 80 is hollow, has opened ends 82 and 84 and has a configuration similar to that of the device 70. In addition, the form has a longitudinal slit 86 rendering the form expandable in a transverse direction. The form further includes tabs 88 and 90 which, when pressed towards each other, cause the form to expand in the transverse direction.
The device 70 is applied to the form 80 until the end 74 of the device 70 is at the end 84 of the form 80 as illustrated in FIG. 7. An atraumatic instrument, such as a forceps 92, is then aligned with the form 80 and moved relative thereto through the form in the direction of arrow 96 and into engagement with the lung tissue 58 as illustrated in FIG. 8.
The forceps 92 are then used to grab the lung tissue 58. Then, the tabs 88 and 90 of the form 80 are pressed toward each other to cause the form 80 to expand in a transverse direction. This may be noticed by the longitudinal slit 86 becoming noticeably wider. The expansion of the form 80 in the transverse direction imparts an expansion force on the device 70, causing it to similarly expand to an expanded condition. With the device 70 thus expanded, the forceps are then retracted as illustrated in FIG. 9 in the direction of arrow 98, to pull the lung tissue into the form 80 and device 70. Preferably, although not necessarily, the lung tissue is pulled until it extends entirely through the device 70.
The process continues as illustrated in FIG. 10. Here, the tabs 88 and 90 are released. Given the volume of lung tissue within the form 80 and device 70, the device 70 remains in an expanded condition. Now, a suitable instrument 94 is used to hold the device 70 in place while the form 80 is moved in the direction of the arrow 100 to withdraw the form 80 from the device 70.
As illustrated in FIG. 11, the process is completed when the form 80 is totally withdrawn from the device 70. In doing so, the expansion force applied to the device 70 by the form 80 is released, permitting the device 70 to collapse or contract about the lung tissue 58 drawn into the device 70. The device 70 now constricts the lung tissue to effect air leak suppression or lung volume reduction, for example.
Alternatively, the form 80 need not be expandable if the device 70 is not expandable. Here, the process of pulling the lung tissue into the mandrel 80 and device 70 will cause the lung tissue to collapse. With the device 70 being dimensioned for constricting the lung tissue, once the mandrel is removed, the lung tissue will remain in and be constricted by the device 70 as illustrated in FIG. 11.
The lung tissue within the device 70 is also now ready to be resectioned. This may be accomplished by severing the device 70 intermediate it's ends using an appropriated bladed instrument.
FIGS. 12-14 illustrate another embodiment of deploying the device 70 in accordance with further aspects of the present invention. Here, rather than using mechanical pulling of the lung tissue into the device 70, vacuum pressure is utilized instead for pulling the lung tissue into the device 70. This permits the procedure to be more automated and potentially less traumatic to the lung tissue being constricted and resectioned.
As will be noted in FIG. 12, the mandrel or form 110 takes the form of a cylinder having an opened end 112 and a closed end 114. The closed end 114 is coupled to a vacuum source 116 through a conduit 118 and a valve 120. The valve 120 has an aperture 122 which, when closed by, for example, a finger 124, causes the vacuum to be pulled through the conduit 118 and form 110. As illustrated in FIG. 12, the valve is in an opened condition.
The form 110 has a diameter dimension 126 which is substantially greater than the diameter dimension of the device 70 when the device is expandable and in a nonexpanded condition. As seen in FIG. 12, the device 70 has been applied over the form 110 so that the form imparts an expansion force to the device 70. The opened end 112 of the form 110 is in contact with the lung tissue 58 to be constricted and resectioned.
Referring now to FIG. 13, the finger 124 has now closed the valve 120. The vacuum is now being pulled through the conduit 118 and form 110. This causes the lung tissue 58 to be pulled into the form 110 and the device 70 while the device 70 is in an expanded condition.
After the lung tissue 58 has been pulled into the form 110 and the device 70, the device may be held in position and the form 110 withdrawn from the device 70 and the lung tissue 58. When this is completed, as best seen in FIG. 14, the vacuum suction may be released by opening the valve 120. More importantly, the expansion force of the form 110 on the device 70 is released to permit the device 70 to collapse or contract about the lung tissue 58. The device 70 is now deployed for constricting the lung tissue and providing leak suppression or lung volume reduction, for example.
Again, the device 70 need not be expandable. To that end, the form 110 may have the same or approximately the same dimensions as the device 70. When the vacuum suction pulls the lung tissue 58 into the mandrel or form 110, it will collapse. After the vacuum suction is terminated and the mandrel 110 removed, the lung tissue 58 will remain in the device 70 in a collapsed condition to be constricted by the device 70. The lung tissue within the device 70 is also ready to be resectioned. Again, this may be accomplished by severing the device 70 intermediate its ends by use of an appropriate bladed instrument.
FIGS. 15-17 illustrate a further embodiment of deploying the device 70 on lung tissue 58 to be constricted and resectioned. Here again, a vacuum suction is utilized for pulling the lung tissue into the device 70.
As illustrated in FIG. 15, the vacuum source 116, the conduit 118, and the valve 120 are again used to establish the vacuum suction in the form 110. Here, however, the device 70 is positioned inside of the form 110 with the end 74 of the device 70 being stretched and held by the lip 130 of the form 110. As a result, when the valve 120 is closed, the vacuum is pulled through the mandrel 110 and the device 70 due to the opened end 72 of the device 70.
Now, when the lung tissue 58 is brought into engagement with the end 74 of the device 70 and the vacuum is pulled with the closure of valve 120, the lung tissue is pulled directly into the device 70 as illustrated in FIG. 16. The vacuum is pulled until the lung tissue 58 to be constricted preferably extends entirely through the device 70 past the end 72. As will be further noted, the lung tissue itself exerts an expansion force on the device 70 as the lung tissue is pulled into the device 70.
After the lung tissue 58 has been pulled into the device 70, the end 74 of the device 70 may be released from the lip 130 of the form 110 to permit the form 110 to be withdrawn from the device 70. When this is completed, as best seen in FIG. 17, the vacuum suction may be released by opening the valve 120. The release of the vacuum also releases the expansion force on the device 70. With the expansion force released, the device is permitted to collapse or contract about the lung tissue 58. The device 70 is now deployed for constricting the lung tissue and providing leak suppression or lung volume reduction, for example. The lung tissue 58 within the device 70 is also in condition for resection. Again, the tissue 58 may be resectioned by severing the device 70 intermediate its ends with a suitable bladed instrument.
Once again, the device 70 need not be expandable. To that end, the form or mandrel 110 may be of the same dimension or slightly larger dimension than the device 70 to permit an effective seal between the lip 130 of mandrel or form 110 and the end 74 of the device 70. The vacuum suction will still be pulled through the form 110 and the device 70. As the vacuum suction pulls the lung tissue into the device 70, the lung tissue collapses. When the vacuum is released and the form 110 is removed, the collapsed lung tissue will remain constricted in the device 70 to provide, for example, lung leakage suppression or lung volume reduction.
Referring now to FIGS. 18 and 19, they more clearly illustrate the manner in which the device 70 may be employed for resectioning the lung tissue to effect lung volume reduction to a greater extent. In accordance with this embodiment, the lung portion 59 of lobe 58 has been pulled through the device 70 and is being constricted by the device 70. The device 70 and the manner of pulling the lung portion 59 therethrough may conform to any of the embodiments previously described herein.
In accordance with this embodiment, the device 70 is formed of severable material, such as, any of the materials previously described. This enables the device 70 to be severed or cut intermediate its ends with a suitable bladed instrument 61 as illustrated in FIG. 19 to section the lung portion 59. The portion of the device 70 remaining on the lobe 58 continues to constrict the lung tissue therein to form an effective seal from leakage. Hence, in accordance with this embodiment of the present invention, lung volume reduction is rendered an available treatment while negating the need of conventional lung sectioning and suturing thus avoiding the potentially severe complications which accompany those procedures.
Referring now to FIGS. 20-22, they illustrate the manner in which the device 70 may be utilized for resectioning heart tissue, such as left atrial appendage tissue. Shown in FIG. 20 is a heart 100 having the device 70 deployed on the left atrial appendage 72. The device 70 may be deployed in accordance with any of the previously described methods for deployment. Preferably, the device 70 is deployed by imparting vacuum suction to the left atrial tissue 74 to be resectioned by a vacuum cylinder 76.
Once the device 70 is deployed as illustrated, the tissue 74 constricted within the device 70 and to be resectioned is resectioned as illustrated in FIG. 21. Here it may be seen that the device 70 has been severed intermediate its ends. This results in the resectioning of the tissue 74. The portion of the device 70 remaining on the left atrial appendage, as seen in FIG. 22, continues to constrict the remaining left atrial appendage tissue 72 and maintains the integrity of the left atrial appendage 72 to prevent leakage and bleeding.
As can thus be seen, in accordance with the present invention, resectioning of the heart may be accomplished without suturing by use of the constriction and resection device 70. This will greatly assist in accelerating the healing process and reducing the potential for infection.
Referring now to FIGS. 23-25, they illustrate the manner in which the device 70 may be utilized for resectioning ovarian tissue. Shown in FIG. 23 is an ovary 110 having the device 70 deployed thereon. The device 70 may be deployed in accordance with any of the previously described methods for deployment. Preferably, the device 70 is deployed by imparting vacuum suction to the ovarian tissue 84 to be resectioned by the vacuum cylinder 76.
Once the device 70 is deployed as illustrated, the tissue 84 constricted within the device 70 and to be resectioned is resectioned as illustrated in FIG. 24. Here it may be seen that the device 70 has been severed intermediate its ends. This results in the resectioning of the tissue 84. The portion of the device 70 remaining on the ovary 110, as seen in FIG. 25, continues to constrict the remaining ovarian tissue 110 and maintains the integrity of the ovary 110 to prevent leakage and bleeding.
Referring now to FIGS. 26-29, they illustrate the manner in which the device 70 may be utilized for resectioning gall bladder tissue. Shown in FIG. 26 is a gall bladder 120 having the device 70 deployed thereon. Again, the device 70 may be deployed in accordance with any of the previously described methods for deployment but preferably is deployed by imparting vacuum suction to the gall bladder tissue 94 to be resectioned by the vacuum cylinder 76.
Once the device 70 is deployed as illustrated, the gall bladder tissue 94 constricted within the device 70 and to be resectioned is resectioned as illustrated in FIG. 27. Here it may be once again seen that the device 70 has been severed intermediate its ends. This results in the resectioning of the tissue 94. The portion of the device 70 remaining on the gall bladder 120, as seen in FIG. 28, continues to constrict the gall bladder tissue 120 to maintain its integrity and to prevent leakage and bleeding.
Referring now to FIGS. 29-31, they illustrate the manner in which the device 70 may be utilized for resectioning pancreatic tissue. Shown in FIG. 29 is a pancreas 130 having the device 70 deployed thereon. The device 70 is preferably deployed by imparting vacuum suction to the pancreatic tissue 104 to be resectioned by the vacuum cylinder 76. Of course, any of the other methods of deployment may be used as well.
Once the device 70 is deployed as illustrated, the tissue 104 constricted within the device 70 and to be resectioned is resectioned as illustrated in FIG. 30. Here it may be seen that the device 70 has been severed intermediate its ends. This results in the resectioning of the tissue 104. The portion of the device 70 remaining on the pancreas 130, as seen in FIG. 31, continues to constrict the remaining pancreatic tissue 130 and maintains the integrity of the pancreas to prevent leakage and bleeding.
FIGS. 32-34 illustrate the manner in which the device 70 may be utilized for resectioning an appendix 140 from its adjoining intestine 138. Shown in FIG. 32 is device 70 deployed over the appendix 140. Again, the device 70 may be deployed in accordance with any of the previously described methods for deployment. Preferably, the device 70 is deployed by imparting vacuum suction to the appendix tissue 140 to be resectioned by the vacuum cylinder 76.
Once the device 70 is deployed on the appendix as illustrated, the appendix tissue 140 constricted within the device 70 and to be resectioned is resectioned as illustrated in FIG. 33. Here it may be seen that the device 70 has been severed intermediate its ends. This results in the resectioning of the appendix 140. The portion of the device 70 remaining on what remains of the appendix 140, as seen in FIG. 34, maintains the integrity of the intestine 138 to prevent leakage and bleeding.
Referring now to FIGS. 35-37, they illustrate a last example as to how the device 70 may be utilized for resectioning body tissue. Here, spleen tissue is to be resectioned. Shown in FIG. 35 is a spleen 150 having the device 70 deployed thereon. As previously described, the device 70 may be deployed in accordance with any of the previously mentioned methods for deployment. Again, preferably, the device 70 is deployed by imparting vacuum suction to the spleen tissue 154 to be resectioned by a vacuum cylinder 76.
Once the device 70 is deployed as illustrated, the tissue 154 constricted within the device 70 and to be resectioned is resectioned as illustrated in FIG. 36. Again, the device 70 has been severed intermediate its ends. This results in the resectioning of the tissue 154. The portion of the device 70 remaining on the spleen 150, as seen in FIG. 22, continues to maintain the integrity of the spleen 150 to prevent leakage and bleeding.
As can thus be seen, in accordance with the present invention, the resectioning may be accomplished without suturing by use of the constricting and resection device 70. This significantly simplifies resectioning procedures. For example, since a vacuum may be utilized to pull the tissue to be resectioned into the device, the area is also aspirated at the same time. This assists in preventing contamination and infection. Also, there is no resulting opened wound by virtue of the resection. This again lends to assist in preventing infection. Resection is rendered substantially an automated procedure since the procedures for deploying the device may be automated. Hence, the present invention provides an improved device and method which may be used to advantage for resectioning body tissue.
While the invention has been described by means of specific embodiments and applications thereof, it is understood that numerous modifications and variations could be made thereto by those skilled in the art without departing from the spirit and scope of the invention. It is therefore to be understood that within the scope of the claims, the invention may be practiced otherwise than as specifically described herein.

Claims (17)

What is claimed is:
1. A system for treating chronic obstructive pulmonary disease body tissue comprising:
a device that has a generally cylindrical shape and is open at a first end and at a second end;
a resilient sheath configured to mount to the first end of the device in a manner where a substantial portion of the sheath resides within the device;
a vacuum source for drawing target lung tissue into the sheath at the first end of the device; and
a severing tool.
2. The system of claim 1, wherein the vacuum source is in communication with the second end of the device.
3. The system of claim 1, wherein a vacuum is drawn through the resilient sheath to draw the target lung tissue into the sheath.
4. A method for treating chronic obstructive pulmonary disease comprising:
expanding a portion of a resilient sheath that has an open end configured to permit lung tissue to be received therethrough;
mounting a portion of the expanded resilient sheath to a delivery device that is substantially rigid and that has an open end configured to receive the lung tissue therethrough;
placing the delivery device at a location that is adjacent said lung tissue;
drawing said lung tissue through the open end of said delivery device and through the open end of said resilient sheath; and
releasing said expanded resilient sheath to permit said sheath to constrict said lung tissue.
5. The method of claim 4, further comprising severing the resilient sheath and the lung tissue drawn therein.
6. The method of claim 4, wherein the lung tissue is drawn into the open end of the delivery device by a vacuum.
7. The method of claim 4, wherein the open end of the resilient sheath is mounted on the delivery device.
8. The method of claim 4, wherein a substantial portion of the sheath resides within the delivery device when mounted to the delivery device.
9. A method for treating body tissue comprising:
expanding a portion of a resilient sheath that has an open end configured to permit target body tissue to be received therethrough;
mounting a portion of the expanded resilient sheath to a delivery device that is substantially rigid and that has an open end configured to receive the body tissue therethrough;
placing the delivery device at a location that is adjacent the body tissue;
drawing the body tissue through the open end of the delivery device and through the open end of the resilient sheath; and
releasing the expanded resilient sheath to permit the sheath to constrict the body tissue.
10. The method of claim 9, further comprising severing the resilient sheath and the body tissue drawn therein.
11. The method of claim 9, wherein the body tissue is drawn into the open end of the delivery device by a vacuum.
12. The method of claim 9, wherein the open end of the resilient sheath is mounted on the delivery device.
13. The method of claim 9, wherein a substantial portion of the sheath resides within the delivery device when mounted to the delivery device.
14. The method of claim 9, wherein placing the delivery device at a location that is adjacent the body tissue comprises selecting a location comprising diseased tissue.
15. The method of claim 9, wherein placing the delivery device at a location that is adjacent the body tissue comprises selecting a location comprising lung tissue.
16. The method of claim 15, wherein the lung tissue location comprises nodules.
17. The method of claim 9, wherein placing the delivery device at a location that is adjacent the body tissue comprises selecting a location comprising tumors.
US13/293,079 2000-03-23 2011-11-09 Tissue resection device, system, and method Expired - Fee Related USRE45921E1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US13/293,079 USRE45921E1 (en) 2000-03-23 2011-11-09 Tissue resection device, system, and method

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US09/534,244 US6328689B1 (en) 2000-03-23 2000-03-23 Lung constriction apparatus and method
US09/780,232 US6485407B2 (en) 2000-03-23 2001-02-09 Tissue resection device, system and method
US10/287,188 US6790172B2 (en) 2000-03-23 2002-11-04 Tissue resection device, system and method
US10/939,811 US7615000B2 (en) 2000-03-23 2004-09-13 Tissue resection device, system, and method
US13/293,079 USRE45921E1 (en) 2000-03-23 2011-11-09 Tissue resection device, system, and method

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/939,811 Reissue US7615000B2 (en) 2000-03-23 2004-09-13 Tissue resection device, system, and method

Publications (1)

Publication Number Publication Date
USRE45921E1 true USRE45921E1 (en) 2016-03-15

Family

ID=24129271

Family Applications (5)

Application Number Title Priority Date Filing Date
US09/534,244 Expired - Lifetime US6328689B1 (en) 1999-08-24 2000-03-23 Lung constriction apparatus and method
US09/780,232 Expired - Lifetime US6485407B2 (en) 2000-03-23 2001-02-09 Tissue resection device, system and method
US10/287,188 Expired - Lifetime US6790172B2 (en) 2000-03-23 2002-11-04 Tissue resection device, system and method
US10/939,811 Ceased US7615000B2 (en) 2000-03-23 2004-09-13 Tissue resection device, system, and method
US13/293,079 Expired - Fee Related USRE45921E1 (en) 2000-03-23 2011-11-09 Tissue resection device, system, and method

Family Applications Before (4)

Application Number Title Priority Date Filing Date
US09/534,244 Expired - Lifetime US6328689B1 (en) 1999-08-24 2000-03-23 Lung constriction apparatus and method
US09/780,232 Expired - Lifetime US6485407B2 (en) 2000-03-23 2001-02-09 Tissue resection device, system and method
US10/287,188 Expired - Lifetime US6790172B2 (en) 2000-03-23 2002-11-04 Tissue resection device, system and method
US10/939,811 Ceased US7615000B2 (en) 2000-03-23 2004-09-13 Tissue resection device, system, and method

Country Status (3)

Country Link
US (5) US6328689B1 (en)
AU (1) AU772080B2 (en)
CA (1) CA2318009C (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10952907B1 (en) 2017-02-18 2021-03-23 Tag Off LLC Acrochordon excising bandage
USD967957S1 (en) 2020-02-28 2022-10-25 Tag Off LLC Skin growth excision apparatus

Families Citing this family (214)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5954766A (en) * 1997-09-16 1999-09-21 Zadno-Azizi; Gholam-Reza Body fluid flow control device
US6997189B2 (en) * 1998-06-05 2006-02-14 Broncus Technologies, Inc. Method for lung volume reduction
US6488689B1 (en) 1999-05-20 2002-12-03 Aaron V. Kaplan Methods and apparatus for transpericardial left atrial appendage closure
US6712812B2 (en) 1999-08-05 2004-03-30 Broncus Technologies, Inc. Devices for creating collateral channels
US6749606B2 (en) 1999-08-05 2004-06-15 Thomas Keast Devices for creating collateral channels
EP1143864B1 (en) 1999-08-05 2004-02-04 Broncus Technologies, Inc. Methods and devices for creating collateral channels in the lungs
US6328689B1 (en) 2000-03-23 2001-12-11 Spiration, Inc., Lung constriction apparatus and method
US6679264B1 (en) 2000-03-04 2004-01-20 Emphasys Medical, Inc. Methods and devices for use in performing pulmonary procedures
US8474460B2 (en) 2000-03-04 2013-07-02 Pulmonx Corporation Implanted bronchial isolation devices and methods
US20030070683A1 (en) * 2000-03-04 2003-04-17 Deem Mark E. Methods and devices for use in performing pulmonary procedures
US6514290B1 (en) 2000-03-31 2003-02-04 Broncus Technologies, Inc. Lung elastic recoil restoring or tissue compressing device and method
US7033373B2 (en) 2000-11-03 2006-04-25 Satiety, Inc. Method and device for use in minimally invasive placement of space-occupying intragastric devices
US7798147B2 (en) 2001-03-02 2010-09-21 Pulmonx Corporation Bronchial flow control devices with membrane seal
US9345460B2 (en) 2001-04-24 2016-05-24 Cardiovascular Technologies, Inc. Tissue closure devices, device and systems for delivery, kits and methods therefor
US20080109030A1 (en) 2001-04-24 2008-05-08 Houser Russell A Arteriotomy closure devices and techniques
US8961541B2 (en) 2007-12-03 2015-02-24 Cardio Vascular Technologies Inc. Vascular closure devices, systems, and methods of use
US8992567B1 (en) 2001-04-24 2015-03-31 Cardiovascular Technologies Inc. Compressible, deformable, or deflectable tissue closure devices and method of manufacture
US7083629B2 (en) * 2001-05-30 2006-08-01 Satiety, Inc. Overtube apparatus for insertion into a body
US6558400B2 (en) 2001-05-30 2003-05-06 Satiety, Inc. Obesity treatment tools and methods
US6491706B1 (en) * 2001-07-10 2002-12-10 Spiration, Inc. Constriction device including fixation structure
US6860847B2 (en) * 2001-07-10 2005-03-01 Spiration, Inc. Constriction device viewable under X ray fluoroscopy
US6994706B2 (en) 2001-08-13 2006-02-07 Minnesota Medical Physics, Llc Apparatus and method for treatment of benign prostatic hyperplasia
US7708712B2 (en) 2001-09-04 2010-05-04 Broncus Technologies, Inc. Methods and devices for maintaining patency of surgically created channels in a body organ
US20030050648A1 (en) 2001-09-11 2003-03-13 Spiration, Inc. Removable lung reduction devices, systems, and methods
EP1434615B1 (en) 2001-10-11 2007-07-11 Emphasys Medical, Inc. Bronchial flow control device
US6589161B2 (en) * 2001-10-18 2003-07-08 Spiration, Inc. Constriction device including tear resistant structures
US6592594B2 (en) 2001-10-25 2003-07-15 Spiration, Inc. Bronchial obstruction device deployment system and method
US10098640B2 (en) 2001-12-04 2018-10-16 Atricure, Inc. Left atrial appendage devices and methods
US6929637B2 (en) 2002-02-21 2005-08-16 Spiration, Inc. Device and method for intra-bronchial provision of a therapeutic agent
WO2003075796A2 (en) * 2002-03-08 2003-09-18 Emphasys Medical, Inc. Methods and devices for inducing collapse in lung regions fed by collateral pathways
US20030216769A1 (en) 2002-05-17 2003-11-20 Dillard David H. Removable anchored lung volume reduction devices and methods
US20030181922A1 (en) 2002-03-20 2003-09-25 Spiration, Inc. Removable anchored lung volume reduction devices and methods
WO2003082076A2 (en) 2002-03-25 2003-10-09 Nmt Medical, Inc. Patent foramen ovale (pfo) closure clips
US20030195385A1 (en) * 2002-04-16 2003-10-16 Spiration, Inc. Removable anchored lung volume reduction devices and methods
US7527634B2 (en) * 2002-05-14 2009-05-05 University Of Pittsburgh Device and method of use for functional isolation of animal or human tissues
WO2003103476A2 (en) 2002-06-05 2003-12-18 Nmt Medical, Inc. Patent foramen ovale (pfo) closure device with radial and circumferential support
EP1524942B1 (en) 2002-07-26 2008-09-10 Emphasys Medical, Inc. Bronchial flow control devices with membrane seal
US6746460B2 (en) 2002-08-07 2004-06-08 Satiety, Inc. Intra-gastric fastening devices
US7033384B2 (en) 2002-08-30 2006-04-25 Satiety, Inc. Stented anchoring of gastric space-occupying devices
US7214233B2 (en) 2002-08-30 2007-05-08 Satiety, Inc. Methods and devices for maintaining a space occupying device in a relatively fixed location within a stomach
US8123698B2 (en) * 2002-10-07 2012-02-28 Suros Surgical Systems, Inc. System and method for minimally invasive disease therapy
US7220237B2 (en) 2002-10-23 2007-05-22 Satiety, Inc. Method and device for use in endoscopic organ procedures
CA2503349A1 (en) * 2002-11-06 2004-05-27 Nmt Medical, Inc. Medical devices utilizing modified shape memory alloy
US7814912B2 (en) 2002-11-27 2010-10-19 Pulmonx Corporation Delivery methods and devices for implantable bronchial isolation devices
DE60329625D1 (en) * 2002-11-27 2009-11-19 Pulmonx Corp INTRODUCTION FOR IMPLANTABLE BRONCHIAL INSULATION DEVICES
EP1572003B1 (en) 2002-12-09 2017-03-08 W.L. Gore & Associates, Inc. Septal closure devices
US7100616B2 (en) 2003-04-08 2006-09-05 Spiration, Inc. Bronchoscopic lung volume reduction method
US7175638B2 (en) 2003-04-16 2007-02-13 Satiety, Inc. Method and devices for modifying the function of a body organ
US7497857B2 (en) 2003-04-29 2009-03-03 Medtronic, Inc. Endocardial dispersive electrode for use with a monopolar RF ablation pen
US7811274B2 (en) 2003-05-07 2010-10-12 Portaero, Inc. Method for treating chronic obstructive pulmonary disease
US7426929B2 (en) 2003-05-20 2008-09-23 Portaero, Inc. Intra/extra-thoracic collateral ventilation bypass system and method
US7533667B2 (en) 2003-05-29 2009-05-19 Portaero, Inc. Methods and devices to assist pulmonary decompression
US7252086B2 (en) 2003-06-03 2007-08-07 Cordis Corporation Lung reduction system
US7377278B2 (en) 2003-06-05 2008-05-27 Portaero, Inc. Intra-thoracic collateral ventilation bypass system and method
US7494459B2 (en) * 2003-06-26 2009-02-24 Biophan Technologies, Inc. Sensor-equipped and algorithm-controlled direct mechanical ventricular assist device
US20060167334A1 (en) * 2003-06-26 2006-07-27 Anstadt Mark P Method and apparatus for direct mechanical ventricular actuation with favorable conditioning and minimal heart stress
US9861346B2 (en) 2003-07-14 2018-01-09 W. L. Gore & Associates, Inc. Patent foramen ovale (PFO) closure device with linearly elongating petals
US8480706B2 (en) 2003-07-14 2013-07-09 W.L. Gore & Associates, Inc. Tubular patent foramen ovale (PFO) closure device with catch system
ES2428967T3 (en) 2003-07-14 2013-11-12 W.L. Gore & Associates, Inc. Oval foramen tubular permeable closure device (FOP) with retention system
US7682332B2 (en) 2003-07-15 2010-03-23 Portaero, Inc. Methods to accelerate wound healing in thoracic anastomosis applications
US8308682B2 (en) 2003-07-18 2012-11-13 Broncus Medical Inc. Devices for maintaining patency of surgically created channels in tissue
US7533671B2 (en) 2003-08-08 2009-05-19 Spiration, Inc. Bronchoscopic repair of air leaks in a lung
US7963952B2 (en) 2003-08-19 2011-06-21 Wright Jr John A Expandable sheath tubing
US20050103340A1 (en) * 2003-08-20 2005-05-19 Wondka Anthony D. Methods, systems & devices for endobronchial ventilation and drug delivery
US20120289859A9 (en) * 2003-08-27 2012-11-15 Nicoson Zachary R System and method for minimally invasive disease therapy
US8172770B2 (en) 2005-09-28 2012-05-08 Suros Surgical Systems, Inc. System and method for minimally invasive disease therapy
WO2005034764A1 (en) * 2003-09-12 2005-04-21 Nmt Medical, Inc. Device and methods for preventing formation of thrombi in the left atrial appendage
US7846168B2 (en) 2003-10-09 2010-12-07 Sentreheart, Inc. Apparatus and method for the ligation of tissue
US7914543B2 (en) 2003-10-14 2011-03-29 Satiety, Inc. Single fold device for tissue fixation
US7097650B2 (en) 2003-10-14 2006-08-29 Satiety, Inc. System for tissue approximation and fixation
US20050273119A1 (en) 2003-12-09 2005-12-08 Nmt Medical, Inc. Double spiral patent foramen ovale closure clamp
US20050149068A1 (en) * 2003-12-17 2005-07-07 Mathew Williams Left atrial appendage exclusion device
US20050177176A1 (en) 2004-02-05 2005-08-11 Craig Gerbi Single-fold system for tissue approximation and fixation
US8828025B2 (en) 2004-02-13 2014-09-09 Ethicon Endo-Surgery, Inc. Methods and devices for reducing hollow organ volume
MXPA06009971A (en) 2004-02-27 2007-08-08 Satiety Inc Methods and devices for reducing hollow organ volume.
US8206684B2 (en) 2004-02-27 2012-06-26 Pulmonx Corporation Methods and devices for blocking flow through collateral pathways in the lung
JP2007526087A (en) 2004-03-03 2007-09-13 エヌエムティー メディカル, インコーポレイティッド Delivery / recovery system for septal occluder
US8628547B2 (en) 2004-03-09 2014-01-14 Ethicon Endo-Surgery, Inc. Devices and methods for placement of partitions within a hollow body organ
US8252009B2 (en) 2004-03-09 2012-08-28 Ethicon Endo-Surgery, Inc. Devices and methods for placement of partitions within a hollow body organ
US9028511B2 (en) 2004-03-09 2015-05-12 Ethicon Endo-Surgery, Inc. Devices and methods for placement of partitions within a hollow body organ
US8449560B2 (en) 2004-03-09 2013-05-28 Satiety, Inc. Devices and methods for placement of partitions within a hollow body organ
US20050234540A1 (en) * 2004-03-12 2005-10-20 Nmt Medical, Inc. Dilatation systems and methods for left atrial appendage
AU2005231323B2 (en) 2004-03-26 2011-03-31 Ethicon Endo-Surgery, Inc Systems and methods for treating obesity
US7806846B2 (en) * 2004-03-30 2010-10-05 Nmt Medical, Inc. Restoration of flow in LAA via tubular conduit
US20050234543A1 (en) * 2004-03-30 2005-10-20 Nmt Medical, Inc. Plug for use in left atrial appendage
US20050267524A1 (en) 2004-04-09 2005-12-01 Nmt Medical, Inc. Split ends closure device
US8361110B2 (en) 2004-04-26 2013-01-29 W.L. Gore & Associates, Inc. Heart-shaped PFO closure device
US7842053B2 (en) 2004-05-06 2010-11-30 Nmt Medical, Inc. Double coil occluder
US8308760B2 (en) 2004-05-06 2012-11-13 W.L. Gore & Associates, Inc. Delivery systems and methods for PFO closure device with two anchors
WO2005110240A1 (en) 2004-05-07 2005-11-24 Nmt Medical, Inc. Catching mechanisms for tubular septal occluder
US7645285B2 (en) 2004-05-26 2010-01-12 Idx Medical, Ltd Apparatus and methods for occluding a hollow anatomical structure
US7775968B2 (en) 2004-06-14 2010-08-17 Pneumrx, Inc. Guided access to lung tissues
US20050288702A1 (en) 2004-06-16 2005-12-29 Mcgurk Erin Intra-bronchial lung volume reduction system
US8926635B2 (en) * 2004-06-18 2015-01-06 Medtronic, Inc. Methods and devices for occlusion of an atrial appendage
US8409219B2 (en) 2004-06-18 2013-04-02 Medtronic, Inc. Method and system for placement of electrical lead inside heart
WO2006009729A2 (en) * 2004-06-18 2006-01-26 Medtronic, Inc. Methods and devices for occlusion of an atrial appendage
US8663245B2 (en) * 2004-06-18 2014-03-04 Medtronic, Inc. Device for occlusion of a left atrial appendage
WO2006014567A2 (en) 2004-07-08 2006-02-09 Pneumrx, Inc. Pleural effusion treatment device, method and material
US7766891B2 (en) 2004-07-08 2010-08-03 Pneumrx, Inc. Lung device with sealing features
US8409167B2 (en) 2004-07-19 2013-04-02 Broncus Medical Inc Devices for delivering substances through an extra-anatomic opening created in an airway
CA2581677C (en) 2004-09-24 2014-07-29 Nmt Medical, Inc. Occluder device double securement system for delivery/recovery of such occluder device
US8876820B2 (en) 2004-10-20 2014-11-04 Atricure, Inc. Surgical clamp
US20060106288A1 (en) 2004-11-17 2006-05-18 Roth Alex T Remote tissue retraction device
WO2006055047A2 (en) 2004-11-18 2006-05-26 Mark Adler Intra-bronchial apparatus for aspiration and insufflation of lung regions distal to placement or cross communication and deployment and placement system therefor
US20060118126A1 (en) * 2004-11-19 2006-06-08 Don Tanaka Methods and devices for controlling collateral ventilation
US7771472B2 (en) 2004-11-19 2010-08-10 Pulmonx Corporation Bronchial flow control devices and methods of use
US8220460B2 (en) 2004-11-19 2012-07-17 Portaero, Inc. Evacuation device and method for creating a localized pleurodesis
US7398782B2 (en) 2004-11-19 2008-07-15 Portaero, Inc. Method for pulmonary drug delivery
EP1816945B1 (en) 2004-11-23 2019-08-21 PneumRx, Inc. Steerable device for accessing a target site
US7824366B2 (en) 2004-12-10 2010-11-02 Portaero, Inc. Collateral ventilation device with chest tube/evacuation features and method
US8060219B2 (en) 2004-12-20 2011-11-15 Cardiac Pacemakers, Inc. Epicardial patch including isolated extracellular matrix with pacing electrodes
US7981065B2 (en) * 2004-12-20 2011-07-19 Cardiac Pacemakers, Inc. Lead electrode incorporating extracellular matrix
US8876791B2 (en) 2005-02-25 2014-11-04 Pulmonx Corporation Collateral pathway treatment using agent entrained by aspiration flow current
US7731651B2 (en) * 2005-03-17 2010-06-08 Spiration, Inc. Device to deploy a resilient sleeve to constrict on body tissue
WO2006102213A1 (en) 2005-03-18 2006-09-28 Nmt Medical, Inc. Catch member for pfo occluder
WO2006110734A2 (en) 2005-04-07 2006-10-19 Sentreheart, Inc. Apparatus and method for the ligation of tissue
JP2009501570A (en) 2005-07-14 2009-01-22 アイディエックス・メディカル・エルティーディー Apparatus and method for occluding a hollow anatomical structure
US8157818B2 (en) 2005-08-01 2012-04-17 Ension, Inc. Integrated medical apparatus for non-traumatic grasping, manipulating and closure of tissue
US20070043416A1 (en) * 2005-08-19 2007-02-22 Cardiac Pacemakers, Inc. Implantable electrode array
US8104474B2 (en) 2005-08-23 2012-01-31 Portaero, Inc. Collateral ventilation bypass system with retention features
US20080200834A1 (en) * 2005-09-28 2008-08-21 Mark Joseph L Introducer device for improved imaging
US7406963B2 (en) 2006-01-17 2008-08-05 Portaero, Inc. Variable resistance pulmonary ventilation bypass valve and method
US8721734B2 (en) 2009-05-18 2014-05-13 Pneumrx, Inc. Cross-sectional modification during deployment of an elongate lung volume reduction device
US9402633B2 (en) 2006-03-13 2016-08-02 Pneumrx, Inc. Torque alleviating intra-airway lung volume reduction compressive implant structures
US8888800B2 (en) 2006-03-13 2014-11-18 Pneumrx, Inc. Lung volume reduction devices, methods, and systems
US8157837B2 (en) 2006-03-13 2012-04-17 Pneumrx, Inc. Minimally invasive lung volume reduction device and method
US8870913B2 (en) 2006-03-31 2014-10-28 W.L. Gore & Associates, Inc. Catch system with locking cap for patent foramen ovale (PFO) occluder
US8551135B2 (en) 2006-03-31 2013-10-08 W.L. Gore & Associates, Inc. Screw catch mechanism for PFO occluder and method of use
US7691151B2 (en) 2006-03-31 2010-04-06 Spiration, Inc. Articulable Anchor
JP5148598B2 (en) 2006-05-03 2013-02-20 ラプトール リッジ, エルエルシー Tissue closure system and method
PL2574287T3 (en) 2007-03-30 2015-10-30 Sentreheart Inc Devices for closing the left atrial appendage
US20080243141A1 (en) 2007-04-02 2008-10-02 Salvatore Privitera Surgical instrument with separate tool head and method of use
US9005242B2 (en) 2007-04-05 2015-04-14 W.L. Gore & Associates, Inc. Septal closure device with centering mechanism
US9138562B2 (en) 2007-04-18 2015-09-22 W.L. Gore & Associates, Inc. Flexible catheter system
US7931641B2 (en) 2007-05-11 2011-04-26 Portaero, Inc. Visceral pleura ring connector
US8163034B2 (en) 2007-05-11 2012-04-24 Portaero, Inc. Methods and devices to create a chemically and/or mechanically localized pleurodesis
US20080281151A1 (en) * 2007-05-11 2008-11-13 Portaero, Inc. Pulmonary pleural stabilizer
US20080283065A1 (en) * 2007-05-15 2008-11-20 Portaero, Inc. Methods and devices to maintain patency of a lumen in parenchymal tissue of the lung
US8062315B2 (en) 2007-05-17 2011-11-22 Portaero, Inc. Variable parietal/visceral pleural coupling
US20080295829A1 (en) * 2007-05-30 2008-12-04 Portaero, Inc. Bridge element for lung implant
EP3272297B1 (en) 2007-09-20 2020-04-22 Sentreheart, Inc. Devices for remote suture management
US8043301B2 (en) 2007-10-12 2011-10-25 Spiration, Inc. Valve loader method, system, and apparatus
US8136230B2 (en) 2007-10-12 2012-03-20 Spiration, Inc. Valve loader method, system, and apparatus
WO2009105432A2 (en) * 2008-02-19 2009-08-27 Portaero, Inc. Devices and methods for delivery of a therapeutic agent through a pneumostoma
US8475389B2 (en) 2008-02-19 2013-07-02 Portaero, Inc. Methods and devices for assessment of pneumostoma function
US8336540B2 (en) 2008-02-19 2012-12-25 Portaero, Inc. Pneumostoma management device and method for treatment of chronic obstructive pulmonary disease
US20130165967A1 (en) 2008-03-07 2013-06-27 W.L. Gore & Associates, Inc. Heart occlusion devices
US9598691B2 (en) 2008-04-29 2017-03-21 Virginia Tech Intellectual Properties, Inc. Irreversible electroporation to create tissue scaffolds
US9198733B2 (en) 2008-04-29 2015-12-01 Virginia Tech Intellectual Properties, Inc. Treatment planning for electroporation-based therapies
US9867652B2 (en) 2008-04-29 2018-01-16 Virginia Tech Intellectual Properties, Inc. Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds
US10448989B2 (en) 2009-04-09 2019-10-22 Virginia Tech Intellectual Properties, Inc. High-frequency electroporation for cancer therapy
US8992517B2 (en) 2008-04-29 2015-03-31 Virginia Tech Intellectual Properties Inc. Irreversible electroporation to treat aberrant cell masses
US10702326B2 (en) 2011-07-15 2020-07-07 Virginia Tech Intellectual Properties, Inc. Device and method for electroporation based treatment of stenosis of a tubular body part
US11254926B2 (en) 2008-04-29 2022-02-22 Virginia Tech Intellectual Properties, Inc. Devices and methods for high frequency electroporation
US10245098B2 (en) 2008-04-29 2019-04-02 Virginia Tech Intellectual Properties, Inc. Acute blood-brain barrier disruption using electrical energy based therapy
US11272979B2 (en) 2008-04-29 2022-03-15 Virginia Tech Intellectual Properties, Inc. System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies
US9283051B2 (en) 2008-04-29 2016-03-15 Virginia Tech Intellectual Properties, Inc. System and method for estimating a treatment volume for administering electrical-energy based therapies
US10238447B2 (en) 2008-04-29 2019-03-26 Virginia Tech Intellectual Properties, Inc. System and method for ablating a tissue site by electroporation with real-time monitoring of treatment progress
US10117707B2 (en) 2008-04-29 2018-11-06 Virginia Tech Intellectual Properties, Inc. System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies
US10272178B2 (en) 2008-04-29 2019-04-30 Virginia Tech Intellectual Properties Inc. Methods for blood-brain barrier disruption using electrical energy
WO2009157908A1 (en) 2008-06-27 2009-12-30 Davol, Inc. Endoscopic vacuum controller
WO2010011661A1 (en) 2008-07-21 2010-01-28 Atricure, Inc. Apparatus and methods for occluding an anatomical structure
US8632605B2 (en) 2008-09-12 2014-01-21 Pneumrx, Inc. Elongated lung volume reduction devices, methods, and systems
US20100114152A1 (en) * 2008-11-06 2010-05-06 Himanshu Shukla Minimally-Invasive Method and Device for Permanently Compressing Tissues within the Body
US8444635B2 (en) * 2008-11-19 2013-05-21 Samuel Victor Lichtenstein Methods for selectively heating tissue
US8347881B2 (en) 2009-01-08 2013-01-08 Portaero, Inc. Pneumostoma management device with integrated patency sensor and method
US9393023B2 (en) 2009-01-13 2016-07-19 Atricure, Inc. Apparatus and methods for deploying a clip to occlude an anatomical structure
US8332641B2 (en) * 2009-01-30 2012-12-11 Freescale Semiconductor, Inc. Authenticated debug access for field returns
US8518053B2 (en) 2009-02-11 2013-08-27 Portaero, Inc. Surgical instruments for creating a pneumostoma and treating chronic obstructive pulmonary disease
JP5612073B2 (en) 2009-04-01 2014-10-22 センターハート・インコーポレイテッドSentreHEART, Inc. Tissue ligation apparatus and its operation
US11638603B2 (en) 2009-04-09 2023-05-02 Virginia Tech Intellectual Properties, Inc. Selective modulation of intracellular effects of cells using pulsed electric fields
US11382681B2 (en) 2009-04-09 2022-07-12 Virginia Tech Intellectual Properties, Inc. Device and methods for delivery of high frequency electrical pulses for non-thermal ablation
US8903488B2 (en) 2009-05-28 2014-12-02 Angiodynamics, Inc. System and method for synchronizing energy delivery to the cardiac rhythm
US9895189B2 (en) 2009-06-19 2018-02-20 Angiodynamics, Inc. Methods of sterilization and treating infection using irreversible electroporation
US20120029556A1 (en) 2009-06-22 2012-02-02 Masters Steven J Sealing device and delivery system
US9636094B2 (en) 2009-06-22 2017-05-02 W. L. Gore & Associates, Inc. Sealing device and delivery system
US8647350B2 (en) * 2009-08-11 2014-02-11 Raptor Ridge, Llc Delivery device and method for compliant tissue fasteners
US8425455B2 (en) 2010-03-30 2013-04-23 Angiodynamics, Inc. Bronchial catheter and method of use
WO2011129893A1 (en) 2010-04-13 2011-10-20 Sentreheart, Inc. Methods and devices for treating atrial fibrillation
US9017349B2 (en) 2010-10-27 2015-04-28 Atricure, Inc. Appendage clamp deployment assist device
US9066741B2 (en) 2010-11-01 2015-06-30 Atricure, Inc. Robotic toolkit
US8636754B2 (en) 2010-11-11 2014-01-28 Atricure, Inc. Clip applicator
US8795241B2 (en) 2011-05-13 2014-08-05 Spiration, Inc. Deployment catheter
US9345532B2 (en) 2011-05-13 2016-05-24 Broncus Medical Inc. Methods and devices for ablation of tissue
US8709034B2 (en) 2011-05-13 2014-04-29 Broncus Medical Inc. Methods and devices for diagnosing, monitoring, or treating medical conditions through an opening through an airway wall
CN103747751B (en) 2011-06-08 2016-12-28 森特里心脏股份有限公司 Knot of tissue bundling device and tensioner thereof
US9770232B2 (en) 2011-08-12 2017-09-26 W. L. Gore & Associates, Inc. Heart occlusion devices
US9265486B2 (en) 2011-08-15 2016-02-23 Atricure, Inc. Surgical device
EP2758010B1 (en) 2011-09-23 2017-02-08 Pulmonx, Inc Implant loading system
US9078665B2 (en) 2011-09-28 2015-07-14 Angiodynamics, Inc. Multiple treatment zone ablation probe
WO2013078235A1 (en) 2011-11-23 2013-05-30 Broncus Medical Inc Methods and devices for diagnosing, monitoring, or treating medical conditions through an opening through an airway wall
US9282973B2 (en) 2012-01-20 2016-03-15 Atricure, Inc. Clip deployment tool and associated methods
US10828019B2 (en) 2013-01-18 2020-11-10 W.L. Gore & Associates, Inc. Sealing device and delivery system
EP3378416B1 (en) 2013-03-12 2020-07-29 Sentreheart, Inc. Tissue ligation devices
EP3062711B1 (en) 2013-10-31 2023-06-21 AtriCure, Inc. Devices for left atrial appendage closure
US10485545B2 (en) 2013-11-19 2019-11-26 Datascope Corp. Fastener applicator with interlock
JP6594901B2 (en) 2014-05-12 2019-10-23 バージニア テック インテレクチュアル プロパティース インコーポレイテッド Selective modulation of intracellular effects of cells using pulsed electric fields
US9808230B2 (en) 2014-06-06 2017-11-07 W. L. Gore & Associates, Inc. Sealing device and delivery system
US10206686B2 (en) * 2014-06-10 2019-02-19 Ethicon Llc Bronchus sealants and methods of sealing bronchial tubes
US10390838B1 (en) 2014-08-20 2019-08-27 Pneumrx, Inc. Tuned strength chronic obstructive pulmonary disease treatment
WO2016100325A1 (en) 2014-12-15 2016-06-23 Virginia Tech Intellectual Properties, Inc. Devices, systems, and methods for real-time monitoring of electrophysical effects during tissue treatment
WO2016154488A2 (en) 2015-03-24 2016-09-29 Sentreheart, Inc. Tissue ligation devices and methods therefor
GB2550099B (en) 2015-03-24 2020-09-02 Gyrus Acmi Inc Airway stent
CN107530070B (en) 2015-03-24 2021-09-28 森特里心脏股份有限公司 Device and method for left atrial appendage closure
JP7137472B2 (en) 2016-02-26 2022-09-14 センターハート・インコーポレイテッド Device and method for left atrial appendage closure
US10980737B1 (en) 2016-03-08 2021-04-20 Samuel Victor Lichtenstein System for treating unwanted tissue using heat and heat activated drugs
US10470839B2 (en) 2016-06-02 2019-11-12 Covidien Lp Assessment of suture or staple line integrity and localization of potential tissue defects along the suture or staple line
US10905492B2 (en) 2016-11-17 2021-02-02 Angiodynamics, Inc. Techniques for irreversible electroporation using a single-pole tine-style internal device communicating with an external surface electrode
US11607537B2 (en) 2017-12-05 2023-03-21 Virginia Tech Intellectual Properties, Inc. Method for treating neurological disorders, including tumors, with electroporation
US11925405B2 (en) 2018-03-13 2024-03-12 Virginia Tech Intellectual Properties, Inc. Treatment planning system for immunotherapy enhancement via non-thermal ablation
US11311329B2 (en) 2018-03-13 2022-04-26 Virginia Tech Intellectual Properties, Inc. Treatment planning for immunotherapy based treatments using non-thermal ablation techniques
WO2019191271A1 (en) 2018-03-28 2019-10-03 Datascope Corp. Device for atrial appendage exclusion
US11896812B1 (en) 2023-01-27 2024-02-13 Lifebridge Technologies Llc Versatile modular heart pump for non-blood contacting ventricular function augmentation
US11383076B2 (en) 2020-10-01 2022-07-12 Lifebridge Technologies, Llc Pump regulation based on heart size and function

Citations (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2816542A (en) 1955-03-17 1957-12-17 Richard B Freeman Prophylactic tube with differential wall thickness
US4075959A (en) 1977-04-06 1978-02-28 The Singer Company Pneumatic thread and fiber feeding devices
US4147346A (en) 1977-03-16 1979-04-03 Anthony Giannetti Easy glide cue guide
US4204282A (en) 1978-05-08 1980-05-27 Bolt Richard A Implantable artificial sphincter
US4205282A (en) 1978-08-21 1980-05-27 Westinghouse Electric Corp. Phase shifting circuit element
US4267839A (en) 1979-09-12 1981-05-19 Repromed, Inc. Surgical instrument for use in reversible sterilization or permanent occlusion procedures
US4641638A (en) * 1985-10-10 1987-02-10 Perry Robert D Sexual erection prothesis and method of use
US4685467A (en) 1985-07-10 1987-08-11 American Hospital Supply Corporation X-ray transparent medical electrodes and lead wires and assemblies thereof
US4685534A (en) 1983-08-16 1987-08-11 Burstein A Lincoln Method and apparatus for control of fluids
US4738249A (en) 1985-03-01 1988-04-19 The Procter & Gamble Company Method and apparatus for augmenting blood circulation
US4799311A (en) 1987-02-26 1989-01-24 Matsutani Seisakusho Co., Ltd. Apparatus for attaching suture to surgical needle
US4881939A (en) 1985-02-19 1989-11-21 The Johns Hopkins University Implantable helical cuff
US4895140A (en) 1988-08-08 1990-01-23 C.P.S. Inc. Device for overcoming male dysfunction or impotence
US5063913A (en) 1990-11-29 1991-11-12 Nyi Franklin H Elbow brace and method for preventing or attenuating tennis elbow
DE9205453U1 (en) 1992-04-22 1992-06-17 Junghans, Cornelius, Dr., 7900 Ulm, De
US5125890A (en) * 1991-02-22 1992-06-30 Bak Medical Products Vacuum-constriction erection aid device
US5127412A (en) 1990-03-14 1992-07-07 Cosmetto Aristodeme J Skin tensioning
US5167568A (en) 1990-11-22 1992-12-01 Stork Pmt Device and installation for selectively removing organs from a slaughtered animal
US5226429A (en) 1991-06-20 1993-07-13 Inamed Development Co. Laparoscopic gastric band and method
US5229176A (en) 1991-06-04 1993-07-20 Minnesota Mining And Manufacturing Company Protective sleeve and method of assembling the protective sleeve to an object to be protected
US5330483A (en) 1992-12-18 1994-07-19 Advanced Surgical Inc. Specimen reduction device
US5330528A (en) 1989-12-01 1994-07-19 British Technology Group Limited Vascular surgical devices
US5350388A (en) 1989-03-07 1994-09-27 Albert Einstein College Of Medicine Of Yeshiva University Hemostasis apparatus and method
US5398844A (en) 1994-01-31 1995-03-21 Boston Scientific Corporation Multiple ligating band dispenser
DE4405831A1 (en) 1994-02-23 1995-08-24 Karlsruhe Forschzent Surgical pouch aids the insertion and removal of organs or tissue
US5503638A (en) 1994-02-10 1996-04-02 Bio-Vascular, Inc. Soft tissue stapling buttress
US5507797A (en) 1993-08-20 1996-04-16 Sumitomo Bakelite Company Limited Slidable kit for endoscopic ligation
US5509891A (en) 1994-12-19 1996-04-23 Deridder; Paul A. Prothesis for male dysfunction
US5513652A (en) 1992-07-13 1996-05-07 Schwartz; Alan N. Male erection facilitation sheaths and methods of using same
WO1996019145A1 (en) 1994-12-20 1996-06-27 C.R. Bard, Inc. Reciprocating serial transparent elastic band ligator
US5558617A (en) 1992-07-28 1996-09-24 Vascor, Inc. Cardiac compression band-stay-pad assembly and method of replacing the same
US5578047A (en) 1994-08-16 1996-11-26 Taylor; Jerry W. Hemorrhoid removing device
WO1996040356A1 (en) 1995-06-07 1996-12-19 Ep Technologies, Inc. Atrial appendage stasis reduction procedures and devices
US5593413A (en) 1990-05-14 1997-01-14 Medisys Technologies, Inc. Device for assisting childbirth
US5592950A (en) 1995-02-24 1997-01-14 Alberto Kopelowicz Latex prophylactics
US5681271A (en) 1995-09-25 1997-10-28 Nelson; Ronald E. Ankle brace with relief
US5702343A (en) 1996-10-02 1997-12-30 Acorn Medical, Inc. Cardiac reinforcement device
WO1998001084A1 (en) 1996-07-04 1998-01-15 Carlo Rebuffat Surgical appliance for the treatment of pulmonary emphysema
US5711760A (en) 1993-03-15 1998-01-27 Englewood Research Associates Self-inflating venous boot
US5769892A (en) 1996-10-22 1998-06-23 Mitroflow International Inc. Surgical stapler sleeve for reinforcing staple lines
US5810855A (en) 1995-07-21 1998-09-22 Gore Enterprise Holdings, Inc. Endoscopic device and method for reinforcing surgical staples
US5816249A (en) 1996-04-30 1998-10-06 Kopelowicz; Alberto Latex prophylactics adhered to a deformed knitted fabric and their manufacturing procedure
WO1998048706A1 (en) 1997-04-30 1998-11-05 Bradford Hospitals Nhs Trust Occlusion device
US5870779A (en) 1998-02-05 1999-02-16 Heron; Rodney Undergarment with a testicle pouch and genital space
US5902312A (en) 1995-07-03 1999-05-11 Frater; Dirk A. System for mounting bolster material on tissue staplers
US5916183A (en) 1995-02-17 1999-06-29 Reid; Tony Method and apparatus for treating edema and other swelling disorders
FR2773702A1 (en) 1998-01-16 1999-07-23 Johnson & Johnson Internationa Compression device for haemostasis of organ such as liver
US5954766A (en) 1997-09-16 1999-09-21 Zadno-Azizi; Gholam-Reza Body fluid flow control device
US5972002A (en) 1998-06-02 1999-10-26 Cabot Technology Corporation Apparatus and method for surgical ligation
US5976158A (en) 1997-06-02 1999-11-02 Boston Scientific Corporation Method of using a textured ligating band
US5984963A (en) 1993-03-18 1999-11-16 Medtronic Ave, Inc. Endovascular stents
US6030392A (en) 1995-01-18 2000-02-29 Motorola, Inc. Connector for hollow anatomical structures and methods of use
US6036698A (en) 1998-10-30 2000-03-14 Vivant Medical, Inc. Expandable ring percutaneous tissue removal device
US6048362A (en) 1998-01-12 2000-04-11 St. Jude Medical Cardiovascular Group, Inc. Fluoroscopically-visible flexible graft structures
US6059797A (en) 1998-06-17 2000-05-09 Ensurg, Inc. Self-disposing ligating band dispenser
US6061840A (en) 1998-02-13 2000-05-16 Alligator; Squire Men's anatomic underwear/swimwear
US6076013A (en) 1999-01-14 2000-06-13 Brennan; Edward F. Apparatus and methods for treating congestive heart failure
US6077214A (en) 1998-07-29 2000-06-20 Myocor, Inc. Stress reduction apparatus and method
US6085754A (en) 1998-07-13 2000-07-11 Acorn Cardiovascular, Inc. Cardiac disease treatment method
US6095968A (en) 1998-04-10 2000-08-01 Cardio Technologies, Inc. Reinforcement device
US6155968A (en) 1998-07-23 2000-12-05 Wilk; Peter J. Method and device for improving cardiac function
WO2001002042A1 (en) 1999-07-02 2001-01-11 Pulmonx Methods, systems, and kits for lung volume reduction
US6174323B1 (en) 1998-06-05 2001-01-16 Broncus Technologies, Inc. Method and assembly for lung volume reduction
US6193648B1 (en) 1999-09-21 2001-02-27 Acorn Cardiovascular, Inc. Cardiac constraint with draw string tensioning
FR2798838A1 (en) 1999-09-27 2001-03-30 Innothera Lab Sa STRUCTURE FOR CONTAINING AN ANATOMICAL CHANNEL, IN PARTICULAR A VESSEL
US6224564B1 (en) 1998-06-05 2001-05-01 Leon Korobow Elastic elbow brace
US6230714B1 (en) 1998-11-18 2001-05-15 Acorn Cardiovascular, Inc. Cardiac constraint with prior venus occlusion methods
US6241654B1 (en) 1999-07-07 2001-06-05 Acorn Cardiovasculr, Inc. Cardiac reinforcement devices and methods
US6258100B1 (en) 1999-08-24 2001-07-10 Spiration, Inc. Method of reducing lung size
US6280452B1 (en) 1998-06-22 2001-08-28 Ensurg, Inc. Balloon actuated ligating band dispenser
US6298496B1 (en) 2000-04-18 2001-10-09 Idamae Francesina Evans Protective surgical sock (feet) protective surgical covering for the arm, hand
US6308709B1 (en) 2000-11-22 2001-10-30 Robert M. Paul Erection-facilitating condom
WO2001087170A1 (en) 2000-05-18 2001-11-22 Emphasys Medical, Inc. Bronchiopulmonary occlusion devices and lung volume reduction methods
US6328689B1 (en) 2000-03-23 2001-12-11 Spiration, Inc., Lung constriction apparatus and method
US6342060B1 (en) 1998-12-08 2002-01-29 Brian D. Adams Tendon passing device and method
US6361557B1 (en) 1999-02-05 2002-03-26 Medtronic Ave, Inc. Staplebutton radiopaque marker
US6416554B1 (en) 1999-08-24 2002-07-09 Spiration, Inc. Lung reduction apparatus and method
US6425856B1 (en) 2000-05-10 2002-07-30 Acorn Cardiovascular, Inc. Cardiac disease treatment and device
US6453903B1 (en) 2001-07-13 2002-09-24 Thomas, Iii Kirtis Condom with constrictive band about opening
US6461557B1 (en) 1998-01-09 2002-10-08 Filtertek Inc. Method of molding an O-ring retainer in components using interlocking molds
US6488702B1 (en) 1997-01-24 2002-12-03 Jomed Gmbh Bistable spring construction for a stent and other medical apparatus
US6491706B1 (en) 2001-07-10 2002-12-10 Spiration, Inc. Constriction device including fixation structure
US6514290B1 (en) 2000-03-31 2003-02-04 Broncus Technologies, Inc. Lung elastic recoil restoring or tissue compressing device and method
US6589161B2 (en) 2001-10-18 2003-07-08 Spiration, Inc. Constriction device including tear resistant structures
WO2002022072A3 (en) 2000-09-11 2003-08-14 Closure Medical Corp Bronchial occlusion method and apparatus
WO2001066190A3 (en) 2000-03-04 2003-08-21 Emphasys Medical Inc Methods and devices for use in performing pulmonary procedures
US6620095B2 (en) 2000-12-22 2003-09-16 Syde A. Taheri Cradle-assisted myocardial repair and treatment
US6632239B2 (en) 2001-10-02 2003-10-14 Spiration, Inc. Constriction device including reinforced suture holes
WO2003099141A1 (en) 2002-05-25 2003-12-04 Essam Mohamed Ghareeb Ligating band applicator
US6860847B2 (en) 2001-07-10 2005-03-01 Spiration, Inc. Constriction device viewable under X ray fluoroscopy
US7300442B2 (en) 2001-07-11 2007-11-27 Daniel Cherfas Method of destroying formations in a body
US7338434B1 (en) 2002-08-21 2008-03-04 Medtronic, Inc. Method and system for organ positioning and stabilization
US7399272B2 (en) 2004-03-24 2008-07-15 Medtronic, Inc. Methods and apparatus providing suction-assisted tissue engagement
US7731651B2 (en) 2005-03-17 2010-06-08 Spiration, Inc. Device to deploy a resilient sleeve to constrict on body tissue

Patent Citations (109)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2816542A (en) 1955-03-17 1957-12-17 Richard B Freeman Prophylactic tube with differential wall thickness
US4147346A (en) 1977-03-16 1979-04-03 Anthony Giannetti Easy glide cue guide
US4075959A (en) 1977-04-06 1978-02-28 The Singer Company Pneumatic thread and fiber feeding devices
US4204282A (en) 1978-05-08 1980-05-27 Bolt Richard A Implantable artificial sphincter
US4205282A (en) 1978-08-21 1980-05-27 Westinghouse Electric Corp. Phase shifting circuit element
US4267839A (en) 1979-09-12 1981-05-19 Repromed, Inc. Surgical instrument for use in reversible sterilization or permanent occlusion procedures
US4685534A (en) 1983-08-16 1987-08-11 Burstein A Lincoln Method and apparatus for control of fluids
US4881939A (en) 1985-02-19 1989-11-21 The Johns Hopkins University Implantable helical cuff
US4738249A (en) 1985-03-01 1988-04-19 The Procter & Gamble Company Method and apparatus for augmenting blood circulation
US4685467A (en) 1985-07-10 1987-08-11 American Hospital Supply Corporation X-ray transparent medical electrodes and lead wires and assemblies thereof
US4641638A (en) * 1985-10-10 1987-02-10 Perry Robert D Sexual erection prothesis and method of use
US4799311A (en) 1987-02-26 1989-01-24 Matsutani Seisakusho Co., Ltd. Apparatus for attaching suture to surgical needle
US4895140A (en) 1988-08-08 1990-01-23 C.P.S. Inc. Device for overcoming male dysfunction or impotence
US5350388A (en) 1989-03-07 1994-09-27 Albert Einstein College Of Medicine Of Yeshiva University Hemostasis apparatus and method
US5330528A (en) 1989-12-01 1994-07-19 British Technology Group Limited Vascular surgical devices
US5127412A (en) 1990-03-14 1992-07-07 Cosmetto Aristodeme J Skin tensioning
US5593413A (en) 1990-05-14 1997-01-14 Medisys Technologies, Inc. Device for assisting childbirth
US5167568A (en) 1990-11-22 1992-12-01 Stork Pmt Device and installation for selectively removing organs from a slaughtered animal
US5063913A (en) 1990-11-29 1991-11-12 Nyi Franklin H Elbow brace and method for preventing or attenuating tennis elbow
US5125890A (en) * 1991-02-22 1992-06-30 Bak Medical Products Vacuum-constriction erection aid device
US5229176A (en) 1991-06-04 1993-07-20 Minnesota Mining And Manufacturing Company Protective sleeve and method of assembling the protective sleeve to an object to be protected
US5226429A (en) 1991-06-20 1993-07-13 Inamed Development Co. Laparoscopic gastric band and method
DE9205453U1 (en) 1992-04-22 1992-06-17 Junghans, Cornelius, Dr., 7900 Ulm, De
US5513652A (en) 1992-07-13 1996-05-07 Schwartz; Alan N. Male erection facilitation sheaths and methods of using same
US5558617A (en) 1992-07-28 1996-09-24 Vascor, Inc. Cardiac compression band-stay-pad assembly and method of replacing the same
US5330483A (en) 1992-12-18 1994-07-19 Advanced Surgical Inc. Specimen reduction device
US5711760A (en) 1993-03-15 1998-01-27 Englewood Research Associates Self-inflating venous boot
US5984963A (en) 1993-03-18 1999-11-16 Medtronic Ave, Inc. Endovascular stents
US5507797A (en) 1993-08-20 1996-04-16 Sumitomo Bakelite Company Limited Slidable kit for endoscopic ligation
US5398844A (en) 1994-01-31 1995-03-21 Boston Scientific Corporation Multiple ligating band dispenser
US5503638A (en) 1994-02-10 1996-04-02 Bio-Vascular, Inc. Soft tissue stapling buttress
DE4405831A1 (en) 1994-02-23 1995-08-24 Karlsruhe Forschzent Surgical pouch aids the insertion and removal of organs or tissue
US5578047A (en) 1994-08-16 1996-11-26 Taylor; Jerry W. Hemorrhoid removing device
US5509891A (en) 1994-12-19 1996-04-23 Deridder; Paul A. Prothesis for male dysfunction
WO1996019145A1 (en) 1994-12-20 1996-06-27 C.R. Bard, Inc. Reciprocating serial transparent elastic band ligator
US6030392A (en) 1995-01-18 2000-02-29 Motorola, Inc. Connector for hollow anatomical structures and methods of use
US5916183A (en) 1995-02-17 1999-06-29 Reid; Tony Method and apparatus for treating edema and other swelling disorders
US5592950A (en) 1995-02-24 1997-01-14 Alberto Kopelowicz Latex prophylactics
WO1996040356A1 (en) 1995-06-07 1996-12-19 Ep Technologies, Inc. Atrial appendage stasis reduction procedures and devices
US5902312A (en) 1995-07-03 1999-05-11 Frater; Dirk A. System for mounting bolster material on tissue staplers
US5810855A (en) 1995-07-21 1998-09-22 Gore Enterprise Holdings, Inc. Endoscopic device and method for reinforcing surgical staples
US5681271A (en) 1995-09-25 1997-10-28 Nelson; Ronald E. Ankle brace with relief
US5816249A (en) 1996-04-30 1998-10-06 Kopelowicz; Alberto Latex prophylactics adhered to a deformed knitted fabric and their manufacturing procedure
US6123663A (en) 1996-07-04 2000-09-26 Rebuffat; Carlo Surgical appliance for the treatment of pulmonary emphysema
WO1998001084A1 (en) 1996-07-04 1998-01-15 Carlo Rebuffat Surgical appliance for the treatment of pulmonary emphysema
WO1998014136A1 (en) 1996-10-02 1998-04-09 Acorn Cardiovascular, Inc. Heart volume limiting device
US6126590A (en) 1996-10-02 2000-10-03 Acorn Cardiovascular, Inc. Cardiac reinforcement device
US5702343A (en) 1996-10-02 1997-12-30 Acorn Medical, Inc. Cardiac reinforcement device
US5769892A (en) 1996-10-22 1998-06-23 Mitroflow International Inc. Surgical stapler sleeve for reinforcing staple lines
US6488702B1 (en) 1997-01-24 2002-12-03 Jomed Gmbh Bistable spring construction for a stent and other medical apparatus
WO1998048706A1 (en) 1997-04-30 1998-11-05 Bradford Hospitals Nhs Trust Occlusion device
US5976158A (en) 1997-06-02 1999-11-02 Boston Scientific Corporation Method of using a textured ligating band
US5954766A (en) 1997-09-16 1999-09-21 Zadno-Azizi; Gholam-Reza Body fluid flow control device
US6461557B1 (en) 1998-01-09 2002-10-08 Filtertek Inc. Method of molding an O-ring retainer in components using interlocking molds
US6048362A (en) 1998-01-12 2000-04-11 St. Jude Medical Cardiovascular Group, Inc. Fluoroscopically-visible flexible graft structures
FR2773702A1 (en) 1998-01-16 1999-07-23 Johnson & Johnson Internationa Compression device for haemostasis of organ such as liver
US5870779A (en) 1998-02-05 1999-02-16 Heron; Rodney Undergarment with a testicle pouch and genital space
US6061840A (en) 1998-02-13 2000-05-16 Alligator; Squire Men's anatomic underwear/swimwear
US6095968A (en) 1998-04-10 2000-08-01 Cardio Technologies, Inc. Reinforcement device
US5972002A (en) 1998-06-02 1999-10-26 Cabot Technology Corporation Apparatus and method for surgical ligation
US6224564B1 (en) 1998-06-05 2001-05-01 Leon Korobow Elastic elbow brace
US6174323B1 (en) 1998-06-05 2001-01-16 Broncus Technologies, Inc. Method and assembly for lung volume reduction
US6059797A (en) 1998-06-17 2000-05-09 Ensurg, Inc. Self-disposing ligating band dispenser
US6280452B1 (en) 1998-06-22 2001-08-28 Ensurg, Inc. Balloon actuated ligating band dispenser
US6085754A (en) 1998-07-13 2000-07-11 Acorn Cardiovascular, Inc. Cardiac disease treatment method
US6155968A (en) 1998-07-23 2000-12-05 Wilk; Peter J. Method and device for improving cardiac function
US6077214A (en) 1998-07-29 2000-06-20 Myocor, Inc. Stress reduction apparatus and method
US6036698A (en) 1998-10-30 2000-03-14 Vivant Medical, Inc. Expandable ring percutaneous tissue removal device
US6230714B1 (en) 1998-11-18 2001-05-15 Acorn Cardiovascular, Inc. Cardiac constraint with prior venus occlusion methods
US6342060B1 (en) 1998-12-08 2002-01-29 Brian D. Adams Tendon passing device and method
US6076013A (en) 1999-01-14 2000-06-13 Brennan; Edward F. Apparatus and methods for treating congestive heart failure
US6361557B1 (en) 1999-02-05 2002-03-26 Medtronic Ave, Inc. Staplebutton radiopaque marker
US6709401B2 (en) 1999-07-02 2004-03-23 Pulmonx Methods, systems, and kits for lung volume reduction
US6287290B1 (en) 1999-07-02 2001-09-11 Pulmonx Methods, systems, and kits for lung volume reduction
WO2001002042A1 (en) 1999-07-02 2001-01-11 Pulmonx Methods, systems, and kits for lung volume reduction
US6241654B1 (en) 1999-07-07 2001-06-05 Acorn Cardiovasculr, Inc. Cardiac reinforcement devices and methods
US6293951B1 (en) 1999-08-24 2001-09-25 Spiration, Inc. Lung reduction device, system, and method
US6258100B1 (en) 1999-08-24 2001-07-10 Spiration, Inc. Method of reducing lung size
US6416554B1 (en) 1999-08-24 2002-07-09 Spiration, Inc. Lung reduction apparatus and method
US6193648B1 (en) 1999-09-21 2001-02-27 Acorn Cardiovascular, Inc. Cardiac constraint with draw string tensioning
FR2798838A1 (en) 1999-09-27 2001-03-30 Innothera Lab Sa STRUCTURE FOR CONTAINING AN ANATOMICAL CHANNEL, IN PARTICULAR A VESSEL
US6694979B2 (en) 2000-03-04 2004-02-24 Emphasys Medical, Inc. Methods and devices for use in performing pulmonary procedures
WO2001066190A3 (en) 2000-03-04 2003-08-21 Emphasys Medical Inc Methods and devices for use in performing pulmonary procedures
US6485407B2 (en) * 2000-03-23 2002-11-26 Spiration, Inc. Tissue resection device, system and method
US6790172B2 (en) 2000-03-23 2004-09-14 Spiration, Inc. Tissue resection device, system and method
US7615000B2 (en) 2000-03-23 2009-11-10 Spiration, Inc. Tissue resection device, system, and method
US6328689B1 (en) 2000-03-23 2001-12-11 Spiration, Inc., Lung constriction apparatus and method
US6514290B1 (en) 2000-03-31 2003-02-04 Broncus Technologies, Inc. Lung elastic recoil restoring or tissue compressing device and method
US6298496B1 (en) 2000-04-18 2001-10-09 Idamae Francesina Evans Protective surgical sock (feet) protective surgical covering for the arm, hand
US6425856B1 (en) 2000-05-10 2002-07-30 Acorn Cardiovascular, Inc. Cardiac disease treatment and device
WO2001087170A1 (en) 2000-05-18 2001-11-22 Emphasys Medical, Inc. Bronchiopulmonary occlusion devices and lung volume reduction methods
WO2002022072A3 (en) 2000-09-11 2003-08-14 Closure Medical Corp Bronchial occlusion method and apparatus
US6308709B1 (en) 2000-11-22 2001-10-30 Robert M. Paul Erection-facilitating condom
US6620095B2 (en) 2000-12-22 2003-09-16 Syde A. Taheri Cradle-assisted myocardial repair and treatment
US7347814B2 (en) 2001-07-10 2008-03-25 Alferness Clifton A Constriction device viewable under X ray fluoroscopy
US6860847B2 (en) 2001-07-10 2005-03-01 Spiration, Inc. Constriction device viewable under X ray fluoroscopy
US6491706B1 (en) 2001-07-10 2002-12-10 Spiration, Inc. Constriction device including fixation structure
US7182772B2 (en) 2001-07-10 2007-02-27 Spiration, Inc. Constriction device including fixation structure
US7300442B2 (en) 2001-07-11 2007-11-27 Daniel Cherfas Method of destroying formations in a body
US6453903B1 (en) 2001-07-13 2002-09-24 Thomas, Iii Kirtis Condom with constrictive band about opening
US6632239B2 (en) 2001-10-02 2003-10-14 Spiration, Inc. Constriction device including reinforced suture holes
US20060212051A1 (en) 2001-10-02 2006-09-21 Leslie Snyder Constriction device including reinforced suture holes
US20040097983A1 (en) 2001-10-02 2004-05-20 Leslie Snyder Constriction device including reinforced suture holes
US6843767B2 (en) 2001-10-18 2005-01-18 Spiration, Inc. Constriction device including tear resistant structures
US6589161B2 (en) 2001-10-18 2003-07-08 Spiration, Inc. Constriction device including tear resistant structures
WO2003099141A1 (en) 2002-05-25 2003-12-04 Essam Mohamed Ghareeb Ligating band applicator
US7338434B1 (en) 2002-08-21 2008-03-04 Medtronic, Inc. Method and system for organ positioning and stabilization
US7399272B2 (en) 2004-03-24 2008-07-15 Medtronic, Inc. Methods and apparatus providing suction-assisted tissue engagement
US7731651B2 (en) 2005-03-17 2010-06-08 Spiration, Inc. Device to deploy a resilient sleeve to constrict on body tissue

Non-Patent Citations (15)

* Cited by examiner, † Cited by third party
Title
Bliek, Mark, "Inspecting Small Components with CT Scanners," Jan. 19, 2006, www.medicaldesign.com/articles/ID/12240.
Canadian Office Action for App. No. 2,463,515, dated Sep. 28, 2009.
European Examination Report, re EP Application No. 02800456.2, dated Jan. 3, 2007.
European Search Report, re EP Application No. 02765820.2, dated Jun. 6, 2008.
European, Exam Report, dated Dec. 7, 2009, re EP 02752233.3 in 4 pgs.
European, Supplemental Search Report, dated Sep. 24, 2009, re EP 02752233.3 in 4 pgs.
Int'l Search Report PCT/US2002/031522, dated Dec. 5, 2002.
Japanese First Office Action, re JP Application No. 2003-535671, dated Dec. 9, 2008.
Japanese Office Action, re Application No. 2003-531901, dated Nov. 11, 2008.
Japanese Office Action, re JP Application No. 2003-511697, dated Sep. 9, 2008.
Japanese Office Action, re JP Application No. 2003-511698, dated Sep. 9, 2008.
PCT Invitation to Pay, and PCT Search Report, re PCT Application No. PCT/US2006/009481, mailed Aug. 14, 2006.
PCT Preliminary Report on Patentability, and Written Opinion mailed Sep. 27, 2007, re PCT/US2006/009481.
PCT Search Report and Written Opinion, re PCT Application No. PCT/US2006/009481, mailed Dec. 7, 2006.
Supplementary European Search Report in related European Application dated Feb. 24, 2006.

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10952907B1 (en) 2017-02-18 2021-03-23 Tag Off LLC Acrochordon excising bandage
US11707389B2 (en) 2017-02-18 2023-07-25 Tag Off LLC Acrochordon excising bandage
USD967957S1 (en) 2020-02-28 2022-10-25 Tag Off LLC Skin growth excision apparatus

Also Published As

Publication number Publication date
CA2318009A1 (en) 2001-09-23
US6328689B1 (en) 2001-12-11
US6485407B2 (en) 2002-11-26
AU7242000A (en) 2001-09-27
US20030083542A1 (en) 2003-05-01
US7615000B2 (en) 2009-11-10
CA2318009C (en) 2006-05-02
US20010025132A1 (en) 2001-09-27
AU772080B2 (en) 2004-04-08
US6790172B2 (en) 2004-09-14
US20050043745A1 (en) 2005-02-24

Similar Documents

Publication Publication Date Title
USRE45921E1 (en) Tissue resection device, system, and method
EP1078601B1 (en) Kit for lung volume reduction
US7182772B2 (en) Constriction device including fixation structure
US7347814B2 (en) Constriction device viewable under X ray fluoroscopy
US6632239B2 (en) Constriction device including reinforced suture holes
US6589161B2 (en) Constriction device including tear resistant structures
AU2002362449A1 (en) Constriction device including reinforced suture holes
AU2002353813A1 (en) Constriction device including tear resistant structures
AU2002354640A1 (en) Construction device viewable under X ray fluoroscopy
AU2002329218A1 (en) Constriction device including fixation structure

Legal Events

Date Code Title Description
REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees

Free format text: PATENT EXPIRED FOR FAILURE TO PAY MAINTENANCE FEES (ORIGINAL EVENT CODE: EXP.)

AS Assignment

Owner name: GYRUS ACMI, INC., MASSACHUSETTS

Free format text: MERGER;ASSIGNOR:SPIRATION, INC.;REEL/FRAME:052401/0484

Effective date: 20200401